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Impaired wound healing is an ever-increasing worldwide burden to human health 
affecting especially aged population. Wound healing is a complex process in which 
angiogenesis has a significant role. Recent data suggest that compounds having 
angiogenic effects could improve wound healing. The aim of this study was to investigate 
the effects of different angiogenic (roxadustat, tazarotene, deferoxamine, sodium 
nitroprusside and cobalt chloride) and antiangiogenic (semaxanib) compounds in 
zebrafish and turquoise killifish wound healing models. In addition, the purpose was to 
study the effects of aging on wound healing by comparing the regeneration of caudal fin 
between young and old fish. 
 
The results of the study showed that the regeneration of caudal fin in old zebrafish was 
significantly impaired when compared to young zebrafish. The inhibitory effect of 
semaxanib on fin regeneration was observed in both larval zebrafish and old turquoise 
killifish wound healing models. In turquoise killifish, this finding was also confirmed by 
qRT-PCR as lowered expression of cd34 and by histology as reduced amount of collagen 
in the regenerated caudal fin. However, the regeneration of caudal fin in larval zebrafish 
and old turquoise killifish was not improved after the treatment with angiogenic 
compounds. 
 
In conclusion, both aged zebrafish and aged turquoise killifish can be used to model 
wound healing during aging. However, no improvement on wound healing was observed 
with angiogenic compounds. Further investigation is needed in order to validate the fish 
wound healing models and to find novel treatments for wound healing. 
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1.1 The challenge of impaired wound healing 
 
Impaired wound healing is an ever-increasing worldwide burden to human health. In 
Europe alone, 1.5-2 million people suffer from wounds, either acute or chronic. 
(Lindholm and Searle, 2016) It has been estimated that in developed countries the 
treatment expenses caused by chronic wounds cover 3-5.5% of the total healthcare costs 
(Posnett & Frank, 2008; Philips et al., 2016). Poor wound healing can be associated to 
aging or several underlying diseases, for instance diabetes, vascular disease and cancer, 
or other conditions, such as injury, local-pressure effects or infection (Eming et al., 2014).  
Problems associated with wounds are not only physical, but also mental and social having 
a great impact on the quality of life in patients (Lindholm and Searle, 2016). Impaired 
wound healing may eventually become a mortal condition for the patient (Eming et al., 
2014). For instance, 5-year mortality rate associated to amputations caused by diabetic 
ulcers is 50% (Sargen et al., 2013). 
 
The treatment for chronic wounds is limited due to the complex mechanisms behind 
impaired wound healing. As the prevalence of many chronic diseases associated with 
poor wound healing is increasing, the need for deeper understanding of wound healing 
and new therapies is evident. One of the challenges related to the development of new 
treatments is the lack of preclinical animal models. The complex molecular mechanisms 
involved in human wound healing makes it difficult to develop models that would 
properly mimic human condition. Also, clinical research is challenging due to complex 
and variable patient population with comorbidities. (Eming et al., 2014) 
 




Wound healing in human is a complex process consisting of four overlapping phases 
(figure 1) and involving several different cell types both locally and systemically 
(Rajendran et al., 2018). The first phase of wound healing called hemostasis starts 
immediately after injury and can last up to several hours (Reinke and Sorg, 2012). Acute 
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hypoxia in wound generates reactive oxygen species (ROS), which in turn causes 
vasoconstriction and reduces blood flow that are important for the protection of initial 
wound and thrombus formation (Dunnill et al., 2017). When the blood components 
expose to the subendothelial layer of the blood vessel wall, hemostasis is initiated with 
the help of vasoconstriction and platelet aggregation forms the first hemostatic plug. This 
leads to the initiation of clotting cascade. The formation of thrombin from prothrombin 
results in the generation of fibrin, which forms the blood clot with platelets and 
fibronectin. (Thiruvoth et al., 2015) Blood clot also has a defensive role against microbes, 
and it serves as a matrix for the inflammatory cells. The degranulation of platelets leads 




Figure 1. The phases of wound healing. Normal wound healing proceeds via four 




Hemostasis is followed by the inflammatory phase in wound healing. This phase typically 
lasts from 1 to 3 days. (Reinke and Sorg, 2012) Inflammatory response activates both 
systemic and local defense reactions leading to the recruitment of neutrophils, 
macrophages and lymphocytes. The first white blood cells to populate the wound are 
neutrophils that harness several different strategies to decontaminate the wound. (Roberts 
and Tabares, 1995) Neutrophils secrete antimicrobial peptides and proteases and generate 
ROS (Nathan, 2006). Monocytes take their place after neutrophils as predominant 
inflammatory cells in the wound and differentiate into macrophages (Thiruvoth et al., 
2015). Macrophages phagocytize apoptotic neutrophils, which then results in the 
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elimination of chemokines from the wound area, hence inhibiting further leukocyte 
invasion (Martins-Green et al., 2013). Macrophages have a crucial role in wound closure 
(Eming et al., 2007), and several growth factors and cytokines are also produced by them 
(Novak & Koh, 2013). Growth factors such as FGF, VEGF (also known as VEGF-A), 
TGF‑β, TGF‑α and PDGF are involved in attracting and activating fibroblasts, 
keratinocytes and endothelial cells. These factors also induce cell proliferation, synthesis 
of ECM and have a role in angiogenesis. (Eming et al., 2007; Miao et al., 2013) Finally, 
lymphocytes appear at the wound site and exert a specific reaction to foreign material and 




The third phase of wound healing, called proliferative phase, is characterized by major 
events, such as re-epithelialization, angiogenesis, deposition of ECM and invasion of 
fibroblasts (Thiruvoth et al., 2015). It starts around 4 days post injury and can last up to 
3 weeks (Reinke & Sorg, 2012). Fibroblasts become the predominant type of cells in 
proliferation phase and are activated by different growth factors (Thiruvoth et al., 2015). 
They start to proliferate and produce hyaluronic acid, type III collagen, fibronectin, and 
proteoglycans in order to construct new ECM and a scaffold for the migration of 
keratinocytes (Singer and Clark, 1999).  
 
Fibroblasts and macrophages secrete angiogenic factors, such as VEGF and angiopoietin 
1 (Ang-1) (Johnson and Wilgus, 2014; Kazemi-Lomedasht et al., 2015). New blood 
vessels start to develop from preexisting vessels during the process of granulation tissue 
formation. Granulation tissue gradually replaces fibrin matrix and consists of blood 
vessels, fibroblasts and macrophages embedded in the matrix of collagen, fibronectin and 
hyaluronic acid. (Thiruvoth et al., 2015) 
 
Re‑epithelialization starts in the early phase of wound healing. Keratinocytes at the 
wound edges are activated by EGF and TGF‑β released by the platelets and start to 
proliferate and migrate in order to cover the wound. (Werner et al., 2007; Gillitzer and 
Goebeler, 2001) Matrix metalloproteinases (MMPs) help keratinocytes in their migration 





The final phase of wound healing called remodeling starts approximately 3 weeks after 
injury lasting up to one year or even longer (Reinke and Sorg, 2012). Hypoxia in wound 
bed subsides when the re-epithelialization of the wound progresses. These changes in 
hypoxic conditions may contribute to vessel pruning that takes place during the 
remodeling. (Rodriguez et al., 2019) The tensile strength in the tissue improves by 
degradation, reorganization and resynthesis of ECM (Gonzales et al., 2016). The surface 
of the wound is covered by keratinocytes and the recreation of new stratified epidermis 
progresses from the wound borders towards the inner part of the wound (Martin, 1997). 
As the wound closes, the degradation of type III collagen leads to the increased synthesis 
of type I collagen. Several growth factors, such as TGF-β1 and FGF are involved in the 
regulation of collagen synthesis. (Gonzales et al., 2016) The thickening of collagen fibers 
and their parallel rearrangement increases the tensile strength of the tissue (Doillon et al., 
1985). Due to apoptosis, emigration and other unknown cellular mechanisms, 
inflammatory cells, fibroblasts and majority of the blood vessels start to withdraw from 
the wound leading to scar formation, which is the final outcome in wound healing 
(Gonzales et al., 2016). 
 
1.3 Angiogenesis and wound healing 
 
1.3.1 The phases of angiogenesis 
 
Angiogenesis is a complex, but an essential process in normal wound healing. It is 
typically observed during tissue repair, but also in several disease states. (Johnson and 
Wilgus, 2014) Proliferation, migration and differentiation of endothelial cells into newly 
formed vasculature is needed during the sprouting of new vessels (Carmeliet and Jain, 
2011). Nutrients and oxygen are transported via capillaries into tissues and waste products 
are removed through them (Honnegowda et al., 2015). The process of angiogenesis can 
be divided to three distinctive phases: quiescence, activation and resolution. In healthy 
tissue, blood vessels stay at the quiescent state. The inner surface of the quiescent vessel 
is lined with endothelial cells called phalanx cells. The barrier between these cells is 
created by tight cell-cell adhesion and assists in maintaining blood flow. The cell-cell 
contacts of the quiescent endothelial cells begin to loosen prior to activation by 
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angiogenic factors. When the pericytes detach from the outer surface of the vessel and 
the basement membrane is degraded by MMPs, routes for the development of new 
sprouting vessels are formed. (Carmeliet and Jain, 2011) Growth of the new sprout is 
orchestrated by a single endothelial cell called tip cell. Tip cells conduct the vascular 
outgrowth by responding to the gradient of angiogenic factors. (Gerhardt et al., 2003) 
Adjacent endothelial cells start to proliferate and migrate towards the tip cell leading to 
the elongation of the newly formed vessel. Finally, in the resolution phase of angiogenesis 
the sprouts will fuse with nearby sprouts for establishing blood flow. By contrast, 
unperfused nonfunctional sprouts will regress. (Carmeliet and Jain, 2011)  
 
1.3.2 Angiogenesis in wound healing 
 
Angiogenesis during wound healing is initiated immediately after injury (Honnegowda 
et al., 2015). Several angiogenic factors, such as VEGF, PDGF and Ang-1, are released 
by platelets, macrophages and monocytes for stimulating the proliferation, migration and 
tube formation of endothelial cells (Hellberg et al., 2010; Li et al., 2001). The exposed 
endothelial cells release MMP-2 in order to promote the dissolution of the basement 
membrane, which is a crucial step for angiogenesis (Nguyen et al., 2001). Proteases 
breaking down the tissue matrix also release angiogenic stimulators (Bootle-Wilbraham 
et al., 2001). Hypoxia plays a major role in wound angiogenesis. During the vascular 
proliferation, expression of hypoxia-inducible factor 1α (HIF-1α) triggers the production 
VEGF (Acker and Plate, 2003). Nitric oxide (NO) released by endothelial cells in 
response to hypoxia promotes both angiogenesis and vasodilatation (Smith et al., 2009).  
The stabilization of the vasculature is orchestrated by Ang-1, tyrosine kinase with 
immunoglobulin -like and EGF-like domains 2, pericytes and smooth muscle cells 
(Carmeliet and Jain, 2011). At the final stages of wound healing angiogenesis is 
suppressed (Kumar et al., 2009). As hypoxia and inflammation in the tissue subside, the 
increased levels of growth factors become normalized (Honnegowda et al., 2015). 
 
1.3.3 Angiogenic switch 
 
It is believed that the process of angiogenesis is controlled by the changing levels of 
angiogenic and antiangiogenic factors in the surrounding microenvironment of the 
vasculature. Angiogenic mediators, such as VEGF, PDGF and TGF-β, are involved in 
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stimulating angiogenesis whereas antiangiogenic mediators, such as angiostatin and 
endostatin, inhibit angiogenesis. (Honnegowda et al., 2015) Blood vessels stay at the 
quiescent state when the signal level from antiangiogenic mediators exceeds the level of 
angiogenic factors. When there is a shift in the balance between these opposite factors, 
endothelial cells sense the shift and prepare for angiogenesis. This phenomenon is called 
the angiogenic switch (figure 2) originally used for describing the regulation of 
angiogenesis in tumor growth. (Hanahan and Folkman, 1996)  
 
 
Figure 2. Angiogenic switch. When the switch is “on”, angiogenesis is triggered by 
several different stimulators. When the switch is “off”, inhibitory mediators are involved 
in maintaining blood vessels at the quiescent state. Angiogenic signal can be released for 
instance by inflammatory, hypoxic or tumor cells. Created with BioRender.com. 
 
1.4 Complications in wound repair 
 
1.4.1 Aging-related changes affecting wound repair 
 
Fetal skin has an amazing capability for scarless tissue regeneration (Rowlatt, 1979). This 
capacity in fetus is conserved across several mammalian species (Adzick and Longaker, 
1992). Also, the rate of healing is faster in fetal wound healing and results in complete 
restoration of all skin layers (Rodriquez et al., 2019). However, the transition to scar 
formation from scarless wound healing begins already from the third trimester (Occleston 
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et al., 2008). During aging, the physiological changes start to complicate wound healing 
even more. Advanced age of over 60 is considered an independent risk factor for impaired 
wound healing. (Sgonc and Gruber, 2013) Aging-related changes affect all phases of 
wound healing. For instance, during hemostasis platelet aggregation and degranulation 
are typically increased. (Ashcroft et al., 2002) Delayed infiltration of leucocytes 
characterize the inflammation process (Ashcroft et al., 1998). Due to impaired 
macrophage function, the secretion of proinflammatory mediators is increased and the 
production of VEGF is decreased (Ashcroft et al., 2002). Recent findings suggest that 
insufficiency in VEGF signaling could actually be one the primary drivers in overall 
aging process (Grunewald et al., 2021).  
 
In proliferation phase, delays in the deposition of ECM and collagen together with 
impaired angiogenesis and re-epithelialization are typical age-related changes (Ashcroft 
et al., 2002). Impaired collagen deposition is due to the reduced sensitivity to TGF-β1 
(Mogford et al., 2002) in addition to the decreased fibroblast proliferation and migration 
(Xia et al., 2001). Impaired keratinocyte proliferation and migration further contributes 
to the delayed re-epithelialization in the wound area (Xia et al., 2001). Reduced HIF-1α 
signaling as an indicator of decreased response to hypoxia is involved in the delayed 
angiogenesis in elderly (Chang et al., 2007). In aged skin, the delay in microvascular 
response leads to impaired thermoregulation and hypoperfusion in tissue, which in turn 
inhibits the angiogenic phase of wound healing to initiate. Aging-related decrease in 
vascular density and increase in disorganization of blood vessels further contribute to the 
impairment of transport capacity in skin vasculature. (Bentov and Reed, 2014) Increased 
scarring and decreased collagen turnover characterize the remodeling phase during aging 
(Sgonc and Gruber, 2013).  
 
Many factors are known to affect wound healing during aging. For instance, reduced 
levels of estrogen and androgen complicate wound healing by impairing ECM deposition 
and inflammation control (Sgonc and Gruber, 2013). Malnutrition is fairly common in 
elderly, and together with impaired mobility it can lead to chronic pressure ulcers 
(Mathus-Vliegen, 2004). With advanced age, comorbidities with medications that impair 
wound healing also become more common. Systemic glucocorticoids delay wound 
healing by inhibiting the inflammatory phase whereas chemotherapeutic drugs impair for 
instance cell proliferation, angiogenesis and ECM formation. Also, many diseases that 
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are common in elderly people, such as diabetes or peripheral arterial disease, contribute 
to complications in wound healing. (Sgonc and Gruber, 2013) 
 
1.4.2 Chronic wounds  
 
The mechanisms underlying behind impaired wound repair are poorly understood, but 
several factors are known to complicate wound healing, such as infection in the wound, 
trauma or ischemia. Complications in any of the wound healing phases lead to chronic 
wounds. (Frykberg and Banks, 2015) Wound is considered chronic if it does not heal in 
12 weeks. The primary risk factors for chronic wounds are aging and diabetes. (Wilkinson 
and Hardman, 2020) Typically, chronic wounds are stuck in the inflammatory phase. 
They share many similarities despite different underlying etiologies, such as high levels 
of ROS, proteases, senescent cells with impaired capacity to proliferate and increased 
levels of proinflammatory cytokines as well as dysfunctional stem cells. (Frykberg and 
Banks, 2015) Ongoing tissue injury stimulates the influx of immune cells leading to the 
amplified cascade of proinflammatory cytokines, which in turn leads to the elevated 
protease levels (McCarty and Percival, 2013). High levels of ROS produced by immune 
cells damage proteins in ECM leading to the stimulation of inflammatory cytokines and 
proteases (Schreml et al., 2010). Elevated levels of proteases result in the proteolytic 
destruction of synthetized ECM. More inflammatory cells are attracted by growth factors, 
which in turn amplifies the inflammation. (McCarty and Percival, 2013) Cellular 
senescence is typically observed in several cell types, such as in keratinocytes, fibroblasts, 
macrophages and endothelial cells (Frykberg and Banks, 2015). Senescent cells may also 
become hypersecretory and produce high amounts of proteases and pro-inflammatory 
cytokines (Childs et al., 2015). In addition, microbiota is known to play a significant role 
in chronic wounds, such as in diabetic foot ulcers (Kalan et al., 2019). 
 
1.5 Current treatment of chronic wounds 
 
Correct wound treatment requires a holistic approach in which the underlying causes are 
investigated, and the appropriate treatment is selected based on the patient’s overall 
disease status. For instance, in the management of diabetic ulcers, the treatment starts 
with careful control of blood glucose levels. Depending on the underlying causes, other 
 9 
methods utilized in the treatment of ulcers are compression, exercise, pressure 
distribution, offloading and nutritional support, for instance. (Bowers and Franco, 2020)  
 
Local wound care also consists of several treatments. Debridement of the necrotic tissue 
from the wound has been shown to result in 70.8% rate in wound healing (Wilcox et al., 
2013). Also, the removal of biofilm from the wound with antimicrobial washes is 
essential (Bowers & Franco, 2020). The invisible multicellular community called biofilm 
is associated in 80% of wound infections (Davies, 2003) and can stall the healing process 
in the inflammation phase (Lebrun and Kirsner, 2013). Depending on the etiology of the 
wound, appropriate antiseptic or antibiotic treatment should be started. In the case of 
systemic infections, oral antibiotics should be introduced. (Bowers and Franco, 2020) 
Chronic wounds should also be kept moist with proper dressings as moisture prevents 
infections and accelerates the healing (Field and Kerstein, 1994). 
 
During recent years, the search for new treatments for wound healing has been fierce. 3D 
printing has enabled complex material development, and for instance in 3D wound 
dressings several types of materials can be combined with different drugs. 3D printed 
biomaterials mimic the extracellular matrix, and in the future, it could even be possible 
to produce skin with 3D printers (Okur et al., 2020). Growth factors have also been 
studied for years for their potential in wound healing, but the results have been modest so 
far. The first and only growth factor therapy, PDGF, approved by the Food and Drug 
Administration is used for the topical treatment of diabetic ulcers (Kiwanuka et al., 2012). 
Stem cell and RNA therapies have also shown considerable potential in wound healing 
but results from large clinical trials are still lacking (Okur et al., 2020). 
 
1.6 Angiogenic and antiangiogenic compounds 
 
Several compounds or registered drugs with different indications have been shown to 
have angiogenic properties. Some examples of these are roxadustat, deferoxamine and 
cobalt chloride, that act via HIF pathway (figure 3, table 1). For instance, inhibitor of HIF 
propyl hydroxylase, roxadustat, or FG-4592, is an oral small molecule and the first drug 
in a new class of HIF propyl hydroxylase inhibitors (AstraZeneca, 2021). It was first 
approved for the treatment of anemia of chronic kidney disease in China in 2018 
(FibroGen, 2018). Inhibition of propyl hydroxylase reduces the breakdown of HIF-α and 
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promotes its transcriptional activity. Increased endogenous production of erythropoietin 
via activation of HIF pathway promotes erythropoiesis and improves iron absorption. 
(Besarab et al., 2015) Deferoxamine, also known as desferal or desferrioxamine, is a 
small molecule used for treatment of iron or aluminum toxicity. As a chelating agent it 
binds to free aluminum or iron in the bloodstream forming stable complexes that are 
eliminated via kidneys. (National Center for Biotechnology Information, 2021a) Cobalt 
chloride (CoCl2) is an inorganic compound that inhibits the activity of asparaginyl and 
prolyl hydroxylase and proteasome degradation of HIF-1α (Jaakkola et al., 2001) in 
addition for preventing the incorporation of iron to produce heme (Maines & Sinclair, 
1977), which then results in chemical hypoxia.  
 
 
Figure 3. A simplified figure of the HIF pathway and the mechanisms of action of 
roxadustat, cobalt chloride and deferoxamine. A) Under normoxia HIF-1α breaks down 
by proteasomal degradation. The degradation process is regulated by oxygen when 
hydroxyl groups are added to HIF-1α. After this, von Hippel-Lindau (VHL) protein is 
able to form a complex with HIF-1α, which eventually leads to its degradation. B) During 
hypoxia, the degradation of HIF-1α is protected and it cumulates in nucleus. In nucleus, 
HIF-1α associates with transcription factor aryl hydrocarbon receptor nuclear translocator 
(ARNT) and binds to a specific DNA sequence called hypoxia response element (HRE), 
in the genes regulated by hypoxia. This further leads to the upregulation VEGF, for 
instance. Roxadustat (C), deferoxamine (D) and cobalt chloride (E) all inhibit propyl 
hydroxylase, which is involved in the degradation of HIF-1α. In addition, cobalt chloride 
inhibits the proteasomal degradation of HIF-1α. Adapted and modified from “HIF 




Also, other drugs with different mechanisms of actions, such as sodium nitroprusside and 
tazarotene have been shown to improve angiogenesis (table 1). Vasodilator sodium 
nitroprusside is a drug used for the treatment of acute hypertension and related conditions. 
As a prodrug, it reacts with the sulfhydryl groups on erythrocytes and produces NO that 
relaxes vascular smooth muscles leading to peripheral vasodilation both in veins and 
arteries. (Holme and Sharman, 2020) NO is also involved in several other physiological 
processes, such as in cell proliferation, apoptosis and differentiation (Alderton et al., 
2001), and it is also an important modulator of angiogenesis via VEGF (Conway et al., 
2001).   
 
Tazarotene is a third-generation retinoid used topically for the treatment of acne, plaque 
psoriasis and photodamaged skin. The exact mechanism of action of this small molecule 
is unclear, but it is an agonist for all the retinoid acid receptor subtypes RARa, RARb and 
RARg, and is possibly also involved in gene expression modifications (National Center 
for Biotechnology Information, 2021b). Retinoid acid signaling has been shown to have 
a significant role in the regeneration of zebrafish fin, especially in the formation blastema 
(Blum and Begemann, 2012). 
 
Antiangiogenic drugs are widely used in the treatment of different cancers to inhibit 
tumor growth by suppressing the vascularization in tumors. Small molecule semaxanib, 
or SU5416, is a selective tyrosine-kinase inhibitor of vascular endothelial growth factor 
receptor 2 (VEGFR-2/Flk-1/KDR, table 1). It reached phase III clinical trials in 2002 for 
the treatment of advanced colorectal cancer, but due to discouraging results, the trial was 
terminated prematurely (Cancer Network, 2003). Despite of the discontinued 
development of semaxanib, it is still being widely used for investigative purposes, 
particularly in the studies concerning receptor tyrosine kinases. 
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Table 1. Angiogenic (A) and antiangiogenic (AA) compounds selected for the study with 
mechanisms of actions, relevant findings from previous studies and references. 
 
Compound Mechanism of 
action 









Increased angiogenesis in the 
wounds of diabetic mice* 
 
Enhanced caudal fin 









Inhibition of HIF 
propyl hydroxylase 
Accelerated wound healing in 
diabetic mice* 
 
Improved wound healing in 
aged mice† 
 
Angiogenic properties in 
wound healing, ischemia and 
bone regeneration‡ 








Roxadustat (A) Inhibition of HIF 
propyl hydroxylase  
Increased angiogenesis and 
wound healing in diabetic 
rats*  
 
Improved in vitro motility 
and proliferation of epidermal 
stem cells† 









Formation of NO Accelerates the formation of 
blood vessels in the trunk of 
larval zebrafish* 
 






†Ziche et al., 
1994 









Promotion of endothelial tube 
branching and remodeling in 
vitro, enhanced growth of 
microvessels, accelerated 
wound healing in vivo* 
 
Improved wound repair in 
mice while administered in 
nanoparticle carriers† 
*Al Haj Zen 















Antiangiogenic effects in 
cancer studies both in vitro 
and in vivo* 
 
Delayed wound healing in 
rats† 
*Fong et al., 
1999, Mendel 






1.7 Fish as a model for wound healing 
 
1.7.1 Regenerative capacity in fish 
 
Tissue regeneration is a fascinating mystery among different organisms. Nonmammalian 
vertebrates, such as fish, have an astonishing capability for organ and tissue regeneration 
whereas in humans tissue regeneration is only limited. Cells form the foundation for 
regeneration, and the abundancy of cellular sources is one of the key factors determining 
the regenerative capacity. (Zhao et al., 2016) The cellular mechanisms for regeneration 
include the activation of progenitor or stem cells, dedifferentiation of cells to their 
progenitors and transdifferentation of tissue cells into another type of tissue cells (Jopling 
et al., 2011). Regenerative species either have certain amounts of stem cells preserved or 
have a potential in adult cells for dedifferentiation or transdifferentation. In most adult 
mammals, these mechanisms are however missing, thus their regenerative capacity is 
largely limited. (Knopf et al., 2011) 
Many teleost fish, such as zebrafish, are able to reconstruct their fin after amputation from 
blastema, which is a group of cells having regenerative capability and also the primary 
cue for regeneration (Knopf et al., 2011). The regenerative process in fin starts from 
wound healing and proceeds via blastema and fin ray formation to distal outgrowth and 
differentiation of certain, specialized structures. Amputated wound site in fish fin is 
covered with epithelium in 7 to 12 hours, and proliferation and thickening of the 
epidermal layer takes place in 24 hours. Differentiation occurs 48 hours post injury. In 
this phase, layers of basal cells in addition to connective tissue populated with white blood 
cells are observed. Apical cap, the most distal part of the wound, occurs only by cell 
migration similarly as in skin. After the apical cap has been formed by epithelial cells, 
the remaining epidermal cells start to proliferate and the formation of blastema begins 
within four days after amputation. (Santos-Ruiz et al., 2002) Lineage-restricted 
progenitor cells that populate the fin tissue migrate to the site of amputation to blastema, 
which involves both activation and dedifferentiation of stem cells (Zhao et al., 2016). For 
instance, osteoblasts in fin dedifferentiate temporarily, migrate to blastema and finally 
redifferentiate into osteoblasts again (Knopf et al., 2011). After blastema formation, 
outgrowth of the fin begins by five to seven days after amputation (Misof and Wagner, 
1992). Bone deposition above ray stumps connects the stumps to the newly formed 
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hemirays (Santos-Ruiz et al., 2002). Muscle tissue regeneration starts approximately 
seven days after injury and completes in 10 to 15 days (Ramachandran and Thangavelu, 
1969). 
Several different factors contribute to regeneration. For instance, regeneration may be 
influenced by certain genes. In zebrafish the expression of growth factor Fgf20a suggests 
that regeneration genes are carried by both nonregenerative and regenerative species but 
are involved in regeneration only in the latter (Zhao et al., 2016). Fgf20a is expressed in 
zebrafish after amputation and has a role in the initiation of regeneration (Whitehead et 
al., 2005). In mammals, there is no association of orthologue of Fgf20a with regeneration 
(Zhao et al., 2016). 
Epigenetic regulators have been shown to modulate regenerative processes (Cho et al., 
2013; Gornikiewicz et al., 2013). Differences in DNA methylation have an effect on the 
expression of regeneration-associated genes (Zhao et al., 2016). Histone modifications 
are also involved in zebrafish fin regeneration. For instance, the knockdown of histone 
deacetylase HDAC1 impairs fin regeneration. (Pfefferli et al., 2014) 
Based on several studies it seems that the relationship between the regenerative capacity 
and advanced immune system in different animal species is inverse (Mescher and Neff, 
2005; Aurora and Olson, 2014). For instance, in zebrafish, the capacity for regeneration 
in central nervous system is higher than in mammals and associates with weaker 
inflammatory response after injury than in mammals (Kyritsis et al., 2014).  
1.7.2 Turquoise killifish 
 
Turquoise killifish (Nothobranchius furzeri) is a short-lived annual fish that naturally 
lives in the savannah pools in eastern Africa - area of distinct rainy and dry seasons. The 
embryos of turquoise killifish are extremely tolerant to drought and thus able to survive 
throughout the dry season in dry mud in a dormant state called diapause. During diapause 
the development of the embryos is halted. Embryos start to hatch when the ponds fill up 
with water during rainy season. After this, they grow fast becoming sexually mature in 
only 3 weeks. (Blazek et al., 2013a) The fish die when the ponds desiccate limiting their 
maximal lifespan in nature to under 12 months (Cellerino et al., 2016).  
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The species of turquoise killifish can be divided to several different strains, of which GRZ 
(figure 4) has the shortest median lifespan (Valdesalici and Cellerino, 2003). This inbred 
strain was named after its natural habitat in Gona Re Zhou National Park in Zimbabwe 
and was collected for laboratory use in 1968 (Jubb, 1971). Terzibasi et al. (2008) have 
reported a median lifespan of 9 weeks in GRZ. Its short lifespan is associated with fast 
aging, which can be seen for instance in aging biomarkers and in the behavior of the fish 
(Terzibasi et al., 2008). In addition to GRZ, there are also longer-lived strains available 
for laboratory use. For instance, outbred MZCS222 was collected in 2011 from 
Mozambik (Cellerino et al., 2016). Its median lifespan of 34 weeks has been reported for 
instance by Kosonen (2020). 
 
Based on recent studies, the regenerative capability in aged turquoise killifish is impaired. 
Wendler et al. (2015) noticed in their studies with turquoise killifish strain MZM-0703 
that young, 8-week-old killifish could regrow their caudal fin to its original length in 4 
weeks whereas very old, 54-week-old fish could rebuild only half of the fin, respectively. 
This difference between young and very old fish was statistically significant already at 3 
days after amputation (Wendler et al. 2015). Reduced regenerative capacity associated to 
aging is a phenomenon typical for mammals (Platzer and Englert, 2016). In fact, the aging 
of turquoise killifish resembles mammalian aging in many ways. Killifish have been 
reported to show mitochondrial dysfunction (Hartmann et al., 2011), telomere shortening 
in skin and muscles (Hartmann et al., 2009) and cellular senescence (Genade et al., 2005). 
The short lifespan and fast aging process of turquoise killifish makes it an excellent, cost-
effective tool for aging research (Platzer and Englert, 2016). Based on the finding that 
turquoise killifish loses its regenerative capacity during aging, this fish species is also a 
potential model for investigating the mechanisms associated with aging-related decline 




Figure 4. Turquoise killifish strain GRZ. Adult male of yellow morph in the front and 
smaller, dull female in the back. Turquoise killifish can grow up to 7.5 cm long (Blažek 




Zebrafish (Danio rerio) is a 2-5 cm long teleost (figure 5) naturally living in the 
freshwaters of South Asia (Aleström et al., 2020). In captivity the mean lifespan of 
outbred zebrafish is 3.5 years, but even as high age as 5.5 years has been reported (AnAge, 
2021). Zebrafish has reached wide popularity as a cost-effective model organism in 
biomedical research due to its small size, rapid development, high fecundity and the fact 
that it is easy to breed and maintain in captivity (Nasiadka and Clark, 2012).  Zebrafish 
show similar senescence during aging than humans. Spinal curvature is probably the most 
easily observed sign of aging in zebrafish and is likely due to muscle abnormalities. 
(Gerhard et al., 2002). Lipofuscin accumulation in liver is also observed in aged zebrafish 
in addition to retinal atrophy (Kishi et al., 2008), gene level response to oxidative stress 
(Malek et al., 2004) and decline in reproductive capacity (Kishi et al., 2008). 
 
Zebrafish is one the most widely used vertebrate models for regeneration studies 
(Bernhardt et al., 1996; Poss et al., 2002). The regenerative capacity in zebrafish seems 
to be almost unlimited (Marques et al., 2019). For instance, caudal fin in zebrafish 
regenerates completely even after several amputations (Azevedo et al., 2011; LeClair and 
Topczewiski, 2010). However, subtle changes in the regenerated organs, such as in the 




At least for the heart, age does not seem to restrict the regenerative capacity in zebrafish 
(Itou et al., 2012), but the function of the heart may still be impaired resulting in 
asynchronous contraction of the regenerated area with unaffected heart (Gonzalez-Rosa 
et al., 2014). Itou et al. (2012) reported no decline in aged, 26 - 36-month-old zebrafish 
in the capacity for caudal fin regeneration. Also, Shao et al. (2011) compared the 
regeneration of the caudal fin between 4-, 12-, 18- and 28-month-old zebrafish and 
observed no correlation with age at 48 hours after amputation. However, when the 
regeneration was followed up until 30 days post amputation (dpa), they noticed that in 
18-month-old fish the regenerative capacity is impaired starting from 20 dpa when 
compared to 4- and 12-month-old fish. At 30 dpa, the length of the caudal fin was 90% 
of its original length in 18-months old fish and respectively 95-98% in 4- and 12-month-
old fish. Thus, these results suggest that in aged fish the ability to regenerate caudal fin is 
slightly impaired.  
 
Most of the studies concerning regeneration are performed in adult zebrafish but 
depending on the study and the model in question, also larvae can be used. Using injured 
larvae, compounds can be tested for their pro-regenerative or inhibitory effects on 
regeneration. (Marques et al., 2019)  
 
 
Figure 5. Zebrafish was originally named after its horizontal stripes across the body. 
 
1.8 Aims of the study 
 
Fish wound healing model is a valuable tool to study the mechanisms behind wound 
healing, but also for investigating the potential of different drugs in improving wound 
healing. Angiogenic compounds have been shown to improve wound healing in several 
in vivo studies.  Thus, one of the aims of the present study was to investigate the potential 
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of different angiogenic compounds to improve wound healing in larval zebrafish and 
adult turquoise killifish wound healing models. In order to validate the wound healing 
models, also antiangiogenic compound was included in the study as a potential control. 
 
In addition, the purpose was to study the effects of aging on wound healing by comparing 
the caudal fin regeneration between young and old zebrafish and turquoise killifish. Based 
on earlier somewhat conflicting studies, it was hypothesized in the present study that in 
40-month-old zebrafish the regeneration of caudal fin is impaired when compared to 
young, 4-month-old zebrafish. As aging has been shown to impair wound healing at least 
in old turquoise killifish, the aim was also to investigate if certain genes involved in 
wound healing are affected during the regeneration of caudal fin in young and middle-
aged turquoise killifish. Additionally, in order to perform wound healing studies with a 
convenient, fast-aging fish species, one of the aims of the present study was to set up 
turquoise killifish strain GRZ in laboratory. Caudal fin imaging and length measurements 
in addition to gene expression analyses and histology were selected as investigative 




Impaired wound healing is a significant burden to human health. In normal conditions, 
wound healing proceeds via four overlapping phases. Complications in any of these 
phases may lead to chronic wounds. In elderly people, wound healing is compromised 
due to physiological changes and possible underlying diseases. Angiogenesis also has a 
significant role in wound healing, and it is triggered for instance by hypoxia and VEGF. 
During aging, impaired response to hypoxia contributes to the delay in angiogenesis in 
wound healing. Angiogenic compounds have shown potential in improving wound 
healing in vivo. Zebrafish and turquoise killifish can be used to model wound healing due 
to their capacity to regenerate different tissues, such as fins. In the present study, the 
effects of aging and chosen angiogenic and antiangiogenic compounds on the 





2.1 Survival analyses between turquoise killifish strains GRZ and 
MZCS222 
 
In order to perform wound healing studies with aged turquoise killifish, setting up a short-
lived turquoise killifish strain GRZ in the laboratory was tried. However, several 
challenges were faced due to this. Only 10 fish from 2 different populations successfully 
developed from fertilized eggs into adults and finally reached their natural death. 
However, survival data was collected from the 10 fish that successfully developed into 
adults, and this data was compared with the survival data of turquoise killifish strain 
MZCS222 (figure 6). Collecting survival data from the different strains of turquoise 
killifish is important in each laboratory raising this fish species due to variable living 
conditions in each laboratory. Living conditions, such as food (Terzibasi et al., 2009) and 
tank water (Valenzano et al., 2006) can markedly affect the lifespan of turquoise killifish. 
The survival data of MZCS222 was collected from 4 populations from previous studies 
and partly also during the present study. Possible deaths were recorded daily. The results 
from the survival analyses indicate that the median lifespan of 14 weeks in GRZ is 
significantly shorter (p < 0.0001) than the median lifespan of 33 weeks in MZCS222. 
 
 
Figure 6. The survival rates of turquoise killifish strains GRZ and MZCS222. The 
survival analyses show that the median lifespan for GRZ is 14 weeks (red dashed line) 
and 33 weeks for MZCS222 (black dashed line). The difference between the median 
lifespan of these strains is statistically significant with the p value of < 0.0001 (n=10 in 
GRZ and 77 in MZCS222). Statistical analysis was performed using Log-rank test. A p 
value of < 0.05 was considered significant. 






















) GRZ (median life span 14 weeks)
MZCS222 (median life span 33 weeks)
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2.2 Wound healing studies with turquoise killifish strain MZCS222 
 
2.2.1 Gene expression analyses from the drug study with old fish 
 
The expression of chosen genes involved in angiogenesis was investigated from the 
regenerated pieces of caudal fins collected from a previous drug study with turquoise 
killifish strain MZCS222. In the study by Kosonen (2020), a piece of caudal was 
amputated from old (32 weeks) turquoise killifish, and the fish were treated with either 
angiogenic roxadustat or antiangiogenic semaxanib for 8 days. Control group received 
0.01% DMSO. At the end of the study, a piece of the regenerated part of caudal fin was 
collected for gene expression analyses. To investigate the changes in angiogenesis in the 
regenerated caudal fin between the groups after 8-day drug treatment, the expression of 
angiogenesis-related genes vascular cell adhesion molecule 1 (vcam1), receptor tyrosine 
kinase with immunoglobulin-like and EGF-like domains 1 (tie1), cluster of 
differentiation-34 (cd34) and vegfa were analyzed in the present study. Housekeeping 
gene tata-box binding protein (tbp) was selected as a normalization gene. The results 
(figure 7) are presented as relative quantification values. Four replicates per sample were 
analyzed and sterile water was used as a negative control. The results from the gene 
expression analyses indicate no differences in most of the genes, but in cd34 the 
difference between control and semaxanib group was statistically significant with the p 
value of 0.0103, and in vegfa the p value was close to significant being 0.0528. 
 
 
Figure 7. Expression of certain genes related to angiogenesis in the regenerated turquoise 
killifish strain MZCS222 caudal fin after 8-day treatment. No statistically significant 
differences were observed between the groups in (A) vcam1, (B) tie1 or (D) vegfa. 
However, in (C) cd34 there was a statistical difference between semaxanib and control 
group (*p = 0.0103). n=6-7/group, but only 3 in roxadustat group for vcam1. The results 
were statistically analyzed using one-way ANOVA followed by Dunnett’s multiple 
comparisons test. A p value of < 0.05 was considered significant. 
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2.2.2 Histological analyses from the drug study with old fish 
 
The tissue level effects of roxadustat and semaxanib on the wound healing of turquoise 
killifish strain MZCS222 caudal fin were investigated by Masson-Goldner (MG) staining 
and phospho-histone H3 (PHH3) & collagen-binding adhesion protein 35 (CNA35) 
double staining. In the previous study by Kosonen (2020), half of the regenerated part of 
the caudal fin was stored in 10 % neutral buffered formalin after 8-day drug treatment. In 
the present study, those samples were embedded in paraffin in a frontal plane, sectioned 
and stained with MG for analyzing blood vessel density. Antibody for PHH3 and collagen 
probe CNA35 were used to calculate the mitotic cells and the amount of collagen in the 
tissue. The blood vessel analyses were performed in QuPath software for image analysis 
(Bankhead et al., 2017) whereas mitotic cells and collagen were analyzed in Fiji image 
analysis software (Schindelin et al., 2012). No statistically significant differences in blood 
vessel density were observed in roxadustat or in semaxanib groups when compared to 
control group (figure 8A). The amount of collagen was statistically lower (p = 0.0387) in 
semaxanib group when compared to control group after 8-day treatment (figure 9A). 
However, no significant effects of roxadustat on the amount of collagen in caudal fin 
were observed. In addition, no significant effects of roxadustat on mitotic cells in caudal 
fin were observed, but in semaxanib group the number of mitotic cells was statistically 
higher (p = 0.005) than in control group (figure 9B). Representative images as examples 






Figure 8. (A) Blood vessel density in the caudal fin of turquoise killifish strain MZCS222 
after 8-day drug treatment. No statistically significant differences were observed in 
angiogenic roxadustat or antiangiogenic semaxanib groups when compared to control 
group (n=7/group). The results were statistically analyzed using one-way ANOVA. p 
value of ≤ 0.05 was considered significant. (B) An example of MG staining on turquoise 
killifish caudal fin. Blood vessels can be seen as cavities filled with red blood cells (red 
arrows). Nucleated fish red blood cells are stained bright red, pigment as brown, muscle 
tissue as brick red and connective tissue as turquoise.  
 
 
Figure 9. (A) The amount of collagen (%) from the whole tissue area in the caudal fin of 
turquoise killifish strain MZCS222. The amount of collagen was statistically lower (*p = 
0.0387) in semaxanib group when compared to control group after 8-day treatment (n=6-
7/group). No significant effects of roxadustat on the amount of collagen in caudal fin 
were observed. (B) Mitotic cells (%) from all cells in the caudal fin of turquoise killifish 
strain MZCS222. No significant effects of roxadustat on mitotic cells in caudal fin were 
observed, but in semaxanib group the number of mitotic cells was significantly higher 
(**p = 0.005) than in control group (n=7/group). The results were statistically analyzed 
using one-way ANOVA followed by Dunnett’s multiple comparisons test. A p value of 
< 0.05 was considered significant. 
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Figure 10. An example of PHH3 & CNA35 double staining. Antibody for PHH3 stains 
the mitotic cells (yellow dots) during chromatin condensation at mitosis. CNA35 stains 
the collagen (purple) in the tissue. DAPI was used as a nuclear stain (blue/turquoise).  
 
Due to challenges in analyzing blood vessels from small samples, embedding fin pieces 
on a transverse plane was tried with three samples. These samples were sectioned and 
stained with hematoxylin and eosin (figure 11). The quality of the staining was good, and 
the structure of the fin was clearly visible. However, unfortunately hardly any red blood 




Figure 11. A piece of caudal fin embedded on a transverse plane and stained  
with hematoxylin and eosin. Red arrows indicate nucleated red blood cells in fish. 
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2.2.3 Gene expression analyses from young and middle-aged fish 
 
The differences in the wound healing of caudal fin between young (5 weeks) and middle-
aged (12 weeks) turquoise killifish strain MZCS222 were investigated from the caudal 
fin tissue samples collected in a previous study by Kosonen (2020). To investigate 
possible angiogenesis-related changes during the regeneration of caudal fin at study days 
0 (D0) and 8 (D8), the expression of cd34 and vegfa were analyzed in the present study. 
These differences were also analyzed between young and middle-aged fish. The results 
are presented as relative quantification values, and tbp was used as a normalization gene. 
Water was used as a negative control and four replicates per sample were applied. In 
cd34, no statistical differences were observed between young and middle-aged fish at D0 
or D8 (figure 12A). In addition, the expression of cd34 did not statistically differ between 
D0 and D8 in young or in middle-aged fish. No differences were either observed in the 
expression of vegfa between young and middle-aged fish at D0 (figure 12B). In addition, 
the expression of vegfa did not differ statistically in middle-aged fish between D0 and 
D8. However, in young fish the expression of vegfa was higher (p = 0.0007) at D8 than 
in D0. In addition, the expression of vegfa in young fish was higher (p = 0.0009) at D8 








Figure 12. Gene expression of (A) cd34 and (B) vegfa in the caudal fin of young and 
middle-aged turquoise killifish strain MZCS222 before and after 8-day wound healing 
study. (A) In cd34, no statistical differences between young and old fish at the baseline 
at D0 were observed (n=7/group). In addition, the expression of cd34 did not statistically 
differ between D0 and D8 or after 8-day wound healing study between young and middle-
aged killifish. (B) No differences in the expression of vegfa were observed between young 
and middle-aged fish at D0 (n=6-8/group). In addition, the expression of vegfa did not 
differ statistically in middle-aged fish between D0 and D8. However, in young fish the 
expression of vegfa was higher (***p = 0.0007) at D8 than in D0. In addition, the 
expression of vegfa was higher (***p = 0.0009) at D8 in young fish when compared to 
middle-aged fish. Statistical analyses were performed using two-way ANOVA followed 
by Šidák’s multiple comparisons test. A p value of < 0.05 was considered significant. 
 
2.3 Wound healing studies with zebrafish 
 
2.3.1 Growth length analyses from young and old fish 
 
Differences in wound healing between young (4 months) and old (40 months) male 
zebrafish were investigated by following the regeneration of caudal fin for 8 days. At D0, 
a piece of caudal fin was amputated, and the fin was photographed at D0, D2, D4, D6 and 
D8. The length of the regenerated part of the fin was measured in millimeters in Fiji image 
analysis software (Schindelin et al., 2012) both from the ventral and the dorsal side of the 
fin. Then, the mean value of these two lengths was calculated as percentages from the 
length of the amputated part of the fin at study day 0. The results from the study showed 
that in old fish the regeneration of the caudal fin is significantly impaired at D8 (p = 
0.0004, figure 13) when compared to young fish. The trend towards this can be seen 
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already at earlier time points, and for instance at D6 the p value is nearly significant being 
0.0596. The regeneration of the fin was already observed at D2 with the mean values of 
4 % in growth length for young fish and 1 % for old fish. At D8, the means of the growth 
lengths were 26 % and 7 %, respectively. The growth rate was approximately 3 % per 
day in young and 1 % in old fish. Representative images of the regeneration during the 
study are presented as an example in figure 14. 
 
 
Figure 13. The growth length (%) of zebrafish caudal fin between young and old 
zebrafish during 8-day wound healing study. Statistical difference in growth length 
between young and old zebrafish is significant at D8 (***p = 0.0004), 
n=12/age/timepoint). Bars represent means with SD. Statistical analyses were performed 
using two-way ANOVA followed by Šidák’s multiple comparisons test. A p value of < 
0.05 was considered significant. 
 
 
Figure 14. An example of the regeneration of the caudal fin in young (4 months) and old 
(40 months) zebrafish during 8-day wound healing study. Red line indicates the point for 
caudal fin amputation.  
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In order to evaluate if there are any differences in the regeneration between the dorsal and 
the ventral side of caudal fin, the growth lengths between the sides were compared both 
in young and in old fish (figure 15). Statistically significant differences in the growth 
length between the dorsal and the ventral side of the fin were not observed in young or in 
old zebrafish.  
 
Figure 15. The growth length (%) in the dorsal and in the ventral side of the caudal fin 
in (A) young and (B) old zebrafish during 8-day wound healing study 
(n=12/side/timepoint). No statistical differences in the growth length between the dorsal 
and the ventral side of the fin were observed in young or in old zebrafish. Bars represent 
means with SD. Statistical analyses were performed using two-way ANOVA. A p value 
of < 0.05 was considered significant. 
 
2.3.2 Growth length analyses from the drug study with larval fish 
 
The effects of chosen angiogenic (sodium nitroprusside, tazarotene, roxadustat, 
deferoxamine and cobalt chloride) or antiangiogenic (semaxanib) drugs on the wound 
healing of larval zebrafish Tg(fli:EGFP) caudal fin were investigated in a 48-hour drug 
study. Prior to the treatment, at 2 days post fertilization (dpf) a piece of caudal fin was 
amputated, after which the drug treatment was started. The caudal fin was imaged before 
and after the 48-hour treatment, and its length was measured in Fiji image analysis 
software (Schindelin et al., 2012). The length of the regenerated fin was calculated as 
percentages from a mean total caudal fin length of the uncut control larvae at 4 dpf. For 
comparing the drug effects also untreated control group with caudal fin amputation was 
used. The results showed that the regeneration of the caudal fin was impaired with 10 µM 
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semaxanib concentration (p < 0.0001), but not with the lower doses of 0.1 and 1 µM 
(figure 16A). No improvement on regeneration was seen with sodium nitroprusside 
(figure 16B), deferoxamine (figure 17B) or cobalt chloride (17C). Tazarotene was toxic 
to larvae with all the used concentrations. Due to toxicity the caudal fins of the larvae 
even shrunk (p < 0.0001, figure 16C). Toxicity was also observed with roxadustat. Almost 
all the larvae were lost in the roxadustat groups with the two highest concentrations of 15 
µM and 50 µM. Toxicity was clearly seen also in the group with the lowest dose (2.5 µM) 
in which the growth length of the caudal fin was impaired significantly (p = 0.0008) when 
compared to control group (figure 17A). Representative images of the regeneration of the 
caudal during the 48-hour study and the toxic effects of tazarotene and roxadustat are 
presented as examples in figures 18 and 19. 
 
 
Figure 16. The growth length (%) of the larval zebrafish caudal fin treated with 
semaxanib, sodium nitroprusside or tazarotene.  (A) The regeneration of the caudal fin 
was impaired by with 10 µM semaxanib concentration (****p < 0.0001, n=18-20 in all 
groups). (B) With sodium nitroprusside no statistically significant effects on the growth 
length of the caudal fin were observed with any of the doses (n=12-13/group). (C) 
Tazarotene was toxic with all the used concentrations. Due to toxicity the caudal fins of 
the larvae even shrunk, which can be seen as negative values in growth lengths (****p < 
0.0001, n=19-20/group). The results were statistically analyzed using one-way ANOVA 








Figure 17. The growth length (%) of the larval zebrafish caudal fin treated with 
roxadustat, deferoxamine or cobalt chloride. (A) Toxicity was clearly seen in the 
roxadustat group with the lowest dose in which the growth length of the caudal fin was 
impaired significantly (***p = 0.0008) when compared to control group (n=14 in all 
groups). (B) Deferoxamine showed no statistically significant effects on the caudal fin 
regeneration (n=12-13/group). (C) With cobalt chloride no effects were either seen, 
except for some toxicity in the group with the highest concentration in which 6 larvae 
were lost (n=17-18 in all groups). The results were statistically analyzed using one-way 




Figure 18. Larval zebrafish in semaxanib group during 48-hour wound healing study. 
(A) Larval zebrafish Tg(fli:EGFP) at 2 dpf before caudal fin amputation. The point for 
amputation is marked with red line. (B) Larval zebrafish after caudal fin amputation at 2 
dpf. (C) Larval zebrafish at 4 dpf treated with 10 µM semaxanib for 48 hours. The larva 




Figure 19. Toxic effects of tazarotene and roxadustat in larval zebrafish during 48-hour 
wound healing study. The toxic effects of (B) 9 µM tazarotene dose and (C) 15 µM 
roxadustat dose are clearly visible in the images taken after the 48-hour treatment when 
compared to (A) untreated control group. Developmental deformities can be seen for 
instance in (1) the heart area, (2) yolk sac and (3) intestine. Also, liver situated behind the 





3.1 Laboratory set-up of turquoise killifish strain GRZ 
 
Due to challenges in setting up a fast-aging turquoise killifish strain GRZ in laboratory, 
wound healing studies with GRZ were not possible. These challenges were most likely 
due to several different things. The breeding experiments were carried out based on earlier 
experience in raising turquoise killifish strain MZCS222 and by modifying the protocols 
of Dodzian et al. (2018) and Polačik et al. (2016). In the first hatching experiment, the 
diapausal eggs received from Czech Academy of Science had been stored in dry peat at 
room temperature for several months. The exact number of embryos in the peat was 
unclear as it was difficult to see all the embryos covered in peat, but only 6 fish were 
obtained from the first hatching experiment. As it is known that unsynchronous 
development in annual fish is common (Wourms et al., 1972), it is possible that variable 
number of undeveloped eggs remained in the wettened peat after hatching. In later 
hatching experiments, altogether 4 embryos were obtained. Problems related to those 
experiments are discussed later. 
 
Following hatching, the juvenile fish in the present study were fed with Artemia for the 
first days 2-3 times per day, after which habituation to blood worms was started as the 
fish grew. The feeding with blood worms was narrowed down to once daily 2 weeks post 
hatching. However, according to protocols by Dodzian et al. (2018) and Polačik et al. 
(2016) the energy demand in turquoise killifish is high and the fish should be fed at least 
twice daily. Especially in order to obtain successful egg production, feeding with high 
quality cultured bloodworms, such as Hikari, is recommended (Polačik et al., 2016). After 
facing challenges in egg production in the present study, twice daily feeding with blood 
worms was continued, and the egg production was clearly increased. As there is no 
standardized diet available for laboratory breeding of turquoise killifish (Žak et al., 2020), 
the selection of high-quality food is difficult. Turquoise killifish is reluctant to eat dry 
food complicating its feeding in laboratory conditions (Polačik et al., 2016). The 
problems associated with the use of blood worms are due to the variability in the quality 
of blood worms between suppliers (Dodzian et al., 2018; Polačik et al., 2016). Especially 
when performing aging studies, the use of standardized diet is a prerequisite (Liang et al., 
2018). Although not totally optimal yet, the standardization of the killifish diet is taking 
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important steps. For instance, Žak et al. (2020) tested a pelleted diet in turquoise killifish 
and observed that this dry food was well accepted by the fish at 21 days post hatching.  
 
Even though the effect of twice daily feeding on egg production in the present study was 
clear, the number of eggs was still not optimal, and problems in the incubation of 
fertilized eggs were also faced. A plastic box with sand substrate to trigger spawning 
finally resolved the problems related to egg production, and even several tens of fertilized 
eggs per day were obtained. In the protocol by Dodzian et al. (2018) the use of sand 
substrate is also recommended, and Polačik et al. (2016) recommends glass beads as a 
substrate for spawning.  
 
During egg incubation, some contamination issues were observed. Adding methylene 
blue and gentamicin to the incubation wells prevented bacterial growth, but challenges 
were still faced. For instance, many of the fertilized eggs decayed within few days after 
the start of the incubation. Incubating eggs in peat instead of water is also possible and 
mimics natural conditions better than water. However, incubation in water allows more 
careful observation and control of the embryo development in detail. (Dodzian et al., 
2018) In the present study only incubation in water was tested, and therefore, incubation 
in peat should be tested in the future studies to compare the incubation success between 
these methods. 
 
The constant use of methylene blue and gentamicin during embryo incubation could have 
also caused developmental issues on fish embryos. No studies concerning the effects of 
methylene blue on the development of turquoise killifish has been done, but studies with 
zebrafish embryos/larvae have been performed for instance by Hedge and Sanders 
(2017). They observed no developmental issues with concentrations ranging from 0.624 
to 10 µM after incubating embryos/larvae in methylene blue from 0 to 4 dpf. However, 
in the present study larvae were treated with 0.624 µM methylene blue for several weeks. 
Gentamicin is known to cause ototoxicity (Ton and Parng, 2005; Owens et al., 2009), 
oculotoxicity (Deeti et al., 2014) and behavioral changes (Han et al., 2020) in zebrafish 
embryos and larvae with concentrations ranging from 0.1 to 400 µM. The used exposure 
times in earlier studies have been 24-48 hours. The dose used in the present study was 2 
µM, but the exposure times were up to several weeks, similarly as with methylene blue.  
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In later hatching experiments, some embryos/fish were lost due to unknown reasons 
during hatching. Immediate onset for feeding after hatching is important with turquoise 
killifish (Polačik et al., 2016). Artemia was provided to hatching fish at the start of the 
hatching experiment and at least twice after that during the same day. However, the fish 
were not fed late in the evening causing delays up to 17 hours in the feeding between the 
afternoon and next morning. This may have been problematic, if some of the eggs were 
hatched late in the evening with no possibility for immediate eating. Artemia can live 
only for some hours in fresh water (Brine Shrimp Direct, 2021).  
 
In the protocol by Dodzian et al. (2018) it is recommended that incubation of ready-to-
hatch embryos should not be prolonged more than two weeks, as the viability of the 
embryos will decrease. It is possible that in the present study some of the embryos were 
already overdue at the time of hatching. Poor success in obtaining sensible amounts of 
ready-to-hatch embryos created problems in synchronized hatching as the eggs had to be 
collected during several weeks. 
 
Even though only 10 turquoise killifish of strain GRZ were successfully bred in the 
present study, a small survival analysis was done. Based on the survival analysis, a 
median lifespan of 14 weeks in GRZ was reported (range 12-21 weeks). Terzibasi et al. 
(2008) reported in GRZ a median lifespan of 9 weeks with maximum lifespan of 12 
weeks. This variability clearly indicates differences between laboratories and in their 
environmental conditions. Decreasing water temperature from 25 to 22°C significantly 
lengthens the lifespan of turquoise killifish (Valenzano et al., 2006). Dietary restriction 
in GRZ has been shown to increase the median lifespan from 11.5 to 13 weeks (Terzibasi 
et al., 2009). In the present study, 6 out of 10 fish were fed with blood worms only once 
daily from age 2 to 8 weeks, which likely prolonged the median lifespan of GRZ. 
 
When comparing the median age of GRZ to MZCS222 (33 weeks) in the present study, 
it was observed that the difference between the median lifespans of these strains was 
statistically significant (p < 0.0001). These results clearly indicate that the aging process 
in GRZ is faster than in MZCS222 making it a convenient and cost-effective strain for 
aging studies if the challenges in their breeding can be overcome. 
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3.2 Wound healing studies with turquoise killifish strain MZCS222 
 
3.2.1 Gene expression analyses from young and middle-aged fish 
 
In the study by Kosonen (2020), differences in the wound healing of caudal fin between 
young (5 weeks) and middle-aged (12 weeks) turquoise killifish strain MZCS222 were 
investigated in an 8-day study. In that study, the results showed that in middle-aged fish 
the regeneration of caudal fin was significantly impaired (p < 0.001) starting from study 
day 7 when compared to young fish. In order to investigate angiogenesis-related 
differences in the caudal fin before and after the wound healing study and between young 
and old fish, the expression of cd34 and vegfa were analyzed in the present study.  
 
CD34 is expressed on the filopodia of sprouting tip cells during active angiogenesis 
(Siemerink et al., 2012) and its role in tumor angiogenesis is especially well established. 
The role of CD34 in wound healing has been shown for instance by Qi et al. (2020). In 
their study, the treatment of diabetic ulcers in rats with tacrolimus resulted in mobilization 
of CD34+ endothelial progenitor cells into the wound area and in improved 
microcirculation in diabetic feet. In addition, Lo et al. (2017) showed that CD34 has an 
important role in maintaining vascular integrity in lungs after tissue damage in mice. 
CD34+ mononuclear cell therapy has even been tested in clinical trials for limb ischemia, 
but the results have been inconclusive so far (Pan et al., 2019). There is no data available 
about the possible role of CD34 in the wound healing of turquoise killifish. In the present 
study, no differences in the expression of cd34 were observed when comparing the results 
between young and middle-aged fish or between D0 and D8. However, as it is known that 
angiogenesis during wound healing is impaired in elderly people, the involvement of 
CD34 in the process is possible. Earlier sampling timepoints would offer more data about 
the possible role of CD34 in the early stages of caudal fin regeneration. 
 
VEGF is the key regulator of angiogenesis (Ferrara, 2004). Mechanical injury provokes 
its upregulation via hypoxia on wounded skin. Increased levels of VEGF become 
normalized in the later wound healing stages as the angiogenesis subsides. (Brown et al., 
2002) In the present study, the results from the gene expression analyses showed that the 
expression on vegfa was significantly higher (p < 0.0007) in young fish at D8 when 
compared to D0. Furthermore, the expression of vegfa was also higher (p = 0.0009) at D8 
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in young fish when compared to middle-aged fish. In middle-aged fish, no differences 
were observed between D0 and D8. These results indicate that in young turquoise killifish 
the expression of vegfa increases during 8-day regeneration, but not in middle-aged fish. 
This finding is in line with the observation by Kosonen (2020) that blood vessel density 
was significantly higher in young fish at D8 when compared to middle-aged fish. In 
humans, it is known that low levels of VEGF are associated to chronic wounds and aging-
related decline in wound healing. Complications in wound vascularization due to decline 
in VEGF production seems to contribute to the delay in healing process. (Johnson and 
Wilgus, 2014) Based on the present study, VEGF has a significant role in wound healing 
related angiogenesis also in turquoise killifish.  
 
3.2.2 Gene expression analyses from the drug study 
 
Gene expression analyses were performed in the present study from the samples collected 
by Kosonen (2020) from a wound healing study with drug treatment with turquoise 
killifish strain MZCS222. In the study by Kosonen (2020), old, 32-week-old turquoise 
killifish were treated with angiogenic compound roxadustat or antiangiogenic compound 
semaxanib for 8 days after caudal fin amputation. Treatment with semaxanib resulted in 
decline (p < 0.001) in the growth length already at D6, but no statistically significant 
effects were seen with roxadustat when compared to control group. However, at D8 the 
there was a significant increase (p < 0.01) in the growth rate of caudal fin in roxadustat 
group. (Kosonen, 2020) In order to further elucidate the effects of roxadustat and 
semaxanib on the gene expression in the regenerated caudal fin, analyses for vegfa, cd34, 
tie1 and vcam1 were performed in the present study. There is no previous data available 
from turquoise killifish wound healing studies concerning the effects of roxadustat and 
semaxanib on gene expression analyses selected for the study.  
 
The results in the present study showed that in the fish treated with semaxanib the 
expression of cd34 was lower (p = 0.0103) than in non-treated control group at D8. As 
no differences in the expression of cd34 were observed in the wound healing between 
young and middle-aged turquoise killifish, the results from the drug study suggest that 
the lowered expression of cd34 could be related to the inhibitory effect of semaxanib on 
fin regeneration. In order to evaluate the role of CD34 in the angiogenesis during the 
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wound healing of turquoise killifish more detailed further studies should performed, 
especially regarding the expression of cd34 in old fish.  
 
Based on the results from the present study, there were signs of lowered expression levels 
of vegfa by semaxanib when compared control group, but this finding was not statistically 
significant (p = 0.0528), however. The reason why the effect of semaxanib on the 
expression of vegfa was not clear could be due to the sampling timepoint of the 
regenerated piece of fin. It is possible that the lowest expression level at the time of fin 
sampling at D8 had already passed. However, as the expression level was close to 
significant, repetitive studies with semaxanib and possibly with other VEGFR inhibitors 
would be valuable. Especially analyzing vegfa levels from different timepoints after 
wounding would provide more information about the changes in the gene expression on 
the course of regeneration. VEGFR inhibitors could be also tested for wound healing in 
younger fish in order to see if the expression levels of vegfa are affected accordingly.  
 
No statistically significant effects of semaxanib or roxadustat were seen in the expression 
of tie1 in the present study. Tie1 is expressed on endothelial cells and its deletion has 
been shown to inhibit angiogenesis (D’Amico et al., 2014). As an orphan receptor, the 
effects of Tie1 on angiogenesis are exerted via Ang1/Tie2 signaling (Savant et al., 2015). 
The expression of Tie1 is induced by VEGF and hypoxia (McCarthy et al., 1998), and it 
has even been suggested as a potential target for anti-angiogenic treatments (D’Amico et 
al., 2014). In a study by Korhonen et al. (1992), it was observed that during 
neovascularization of mouse ovarial stroma, Tie expression was increased 3 days post 
wounding and reached the maximum level at day 7 post wounding in newly formed blood 
vessels of granulation tissue. At day 14, the expression had reverted to a lower level 
observed at day 2 (Korhonen et al., 1992). In the light of these findings, it is possible that 
in the present study the wound healing in turquoise killifish had already passed the time 
frame for increased tie1 expression at the time of fin sampling. As no clear effects of 
semaxanib or roxadustat on vegfa were observed, it is possible that this result has further 
affected also on tie1 expression. 
 
The results from the present study showed that the expression of vcam1 was not affected 
by the treatment with semaxanib or roxadustat. The expression of VCAM-1 is especially 
related to the development of different malignant tumors (Chen et al., 2011; Huang et al., 
 37 
2013), but it is also involved in the progression of several inflammatory diseases (Wang 
et al., 2015; Agassandian et al., 2015). VCAM-1 is mainly expressed on vascular 
endothelial cells upon activation (Rice and Bevilacqua, 1989) by inflammatory factors, 
such as TNF-α, but also by ROS, shear stress (Cook-Mills et al., 2011) and VEGF 
(Fearnley et al., 2014; Kim et al., 2001). In a study by Dreßler et al. (1999), the age of 
human skin wound was evaluated by comparing the expression of VCAM-1 between 
uninjured and injured skin using immunohistochemistry. In injured skin, the staining 
reaction for VCAM-1 was positive 3 hours after injury lasting up to 3.5 days post injury. 
(Dreßler et al., 1999) This and the other mentioned studies suggest that VCAM-1 
expression peaks during the inflammatory phase of wound healing. Due to the early 
expression of VCAM-1 during wound healing process it is likely that the regeneration of 
caudal fin in turquoise killifish had already passed the inflammatory phase and reached 
the later phases of repair. However, it is difficult to speculate the results due to the low 
number of samples, especially in roxadustat group, in which there were many samples in 
which the expression of vcam1 was under detectable levels. In order to evaluate the 
significance of vcam1 during the regeneration process in turquoise killifish, gene 
expression analyses should be performed from different timepoints during the caudal fin 
regeneration. 
 
3.2.3 Histological analyses from the drug study 
 
In order to investigate the tissue level effects of the chosen drugs on the regeneration of 
caudal fin, blood vessel density was analyzed from the regenerated caudal fin samples 
collected from the drug study by Kosonen (2020). As the inhibitory effect of semaxanib 
on fin regeneration was seen as a decline in growth length in addition to reduced 
expression of cd34 and amount of collagen in the fin tissue, it would have been 
presumable to find indications of this also in the blood vessel analysis. However, no 
statistical differences were observed in semaxanib or in roxadustat group when 
comparing the blood vessel density to control group.  This result may be biologically 
relevant, or it may relate to the quality of the tissue sections. The tissue sections stained 
with MG were challenging to analyze due to the small size and irregular shape of the fin 
pieces. The samples were also partly transparent and very flexible complicating their 
embedding in paraffin. Therefore, some of the embedded samples were not in the desired 
frontal plane. Based on these difficulties, it was decided to try different orientation of the 
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fin pieces in paraffin embedding. The samples were embedded to paraffin on a transverse 
plane and stained with hematoxylin and eosin. Unfortunately, recognizing blood vessels 
was challenging also from these samples as there were hardly any red blood cells seen in 
the blood vessel cavities. One option to identify blood vessels from transverse sections 
would be to perform immunohistochemistry with endothelial markers, such as CD34 or 
CD31. Also, other analysis methods, such as imaging would be valuable. For instance, 
transparent turquoise killifish strains are under development (Krug, 2021). Optical 
transparency would enable GFP imaging of proliferating or migrating cells and blood 
vessels in transgenic fish.  
 
The effects of roxadustat and semaxanib on cell proliferation in the regenerated caudal 
fin was analyzed from the tissue sections stained with PHH3 antibody. Phosphorylation 
of histone H3 takes place during the chromatin condensation at mitosis (Hans and 
Dimitrov, 2001). Especially the phosphorylation of histone H3 at the residue of serine 10 
is crucial for the onset of mitosis (Nechiporuk and Keating, 2002). Thus, PHH3 antibody 
was used for staining mitotic cells in the tissue. The results from the analysis of PHH3 
staining in the present study were very interesting as the treatment with semaxanib 
seemed to increase the number of mitotic cells in the tissue when compared to control 
group (p = 0.005). Sakao and Tatsumi (2011) investigated the mechanisms behind 
neointimal changes of severe angioproliferative pulmonary hypertension in adult rats 
caused by the combination of hypoxia and semaxanib. They hypothesized that in response 
to the defects in survival signaling by apoptotic cells, conditions that favor 
hyperproliferative, apoptosis-resistant endothelial cells are created (Sakao and Tatsumi, 
2011). This hypothesis could also explain the results from the present study: In response 
to hypoxia caused by the amputation and the treatment with semaxanib, endothelial cells 
in the regenerating caudal fin start to become apoptosis-resistant over time resulting in 
hyperproliferation. This being said, further studies with higher number of fish per group 
are needed in order to understand the tissue level changes during fin regeneration. In 
addition, TUNEL staining for detecting apoptotic cells in the tissue could provide more 
information about the interaction of the cells in the regenerating fin during and after the 
drug treatment.  
 
To investigate the effects of roxadustat and semaxanib on collagen formation during 
caudal fin regeneration, CNA35 staining was performed. CNA35 is a recombinant 
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collagen probe designed for imaging collagen in the tissue (Aper et al., 2014). The results 
from the present study showed that the amount of collagen in the regenerated caudal fin 
was significantly declined in semaxanib group (p = 0.0387) when compared to the control 
group confirming the inhibitory effect of semaxanib on caudal fin regeneration. When 
angiogenesis is inhibited, the later phases of wound healing are also affected resulting in 
decreased formation of collagen. Thus, the results from the present study indicate that the 
regeneration was already in the later phases. With roxadustat, no differences in the 
regenerated caudal fin stained with PHH3 antibody and CNA35 collagen probe were 
observed when compared to control group. This is likely due to the overall modest effect 
of roxadustat on the regeneration of caudal fin. 
 
3.2.4 Administration of the drugs 
 
In the drug study by Kosonen (2020), the administration of the drugs to the fish was 
performed by diluting them in the tank water. This was done daily into fresh water in 
order to keep the tank water clean and to prevent the decay of the drugs in the water. The 
administration of drugs to fish is challenging, especially in the case of small fish. 
Therefore, the use of several administration techniques commonly used with rodents, 
such as oral or intraperitoneal, is limited with fish and often require anesthesia. Also, 
repeated intraperitoneal injections in fish may lead to infection or injury. (Dang et al., 
2016) In the study by Kosonen (2020), diluting the drug in the tank water was justified 
as it simulates the transdermal absorption of topically administered wound treatments in 
humans. As the effects of semaxanib on regeneration were observed with many 
parameters, the absorption of the drug was probably sufficient. However, it remains 
unclear if the absorption of roxadustat was optimal. More concentrations should be tested 
in the future in order to rule out the possibility for too low of a dose. 
 
3.3 Wound healing studies with zebrafish 
 
3.3.1 Wound healing study with young and old zebrafish 
 
Adult zebrafish is able to regenerate its caudal fin within 14-28 days after amputation 
depending for instance on diet, water quality and temperature (Cardeira et al., 2016). 
Several studies suggest that aging does not affect the regenerative capacity in zebrafish 
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(Itou et al., 2012; Panetta et al., 2008), but some functional impairment in different 
organs, such as in heart have been seen (Itou et al., 2012; Gonzalez-Rosa et al., 2014). 
However, for instance Shao et al. (2011) observed a decline in the regenerative capacity 
of 18-month-old zebrafish in the later phases of regeneration. Anchelin et al. (2011) for 
their part showed that in 24-month-old zebrafish the growth rate in caudal fin after 
amputation is significantly lower than in younger (18 months and under) fish.  
 
In the present study, the capacity of 4- and 40-month-old zebrafish to regenerate their 
caudal fin after amputation was investigated. A wound healing study was performed, in 
which the regeneration was followed for 8 days. It was observed that the growth length 
of caudal fin in 40-month-old fish was significantly impaired (p < 0.0004) starting at 8 
dpa when compared to 4-month-old fish. There are no earlier studies concerning caudal 
fin regeneration in zebrafish as old as 40 months, but Itou et al. (2012) reported no decline 
in the regenerative capacity of 26 - 36-month-old zebrafish. The results from the present 
study are partly in line with those observed by Shao et al. (2011) with younger fish. In 
the present study the impairment in regeneration was observed already at 8 dpa whereas 
Shao et al. (2011) reported this decline starting from 20 dpa with 18-month-old zebrafish. 
Anchelin et al. (2011) also found that in 24-month-old zebrafish the decline was 
significant at 12 dpa when compared to younger fish. These findings suggest that the 
decline in the regeneration of caudal fin is associated with age and appears earlier during 
the regeneration process in old than in young fish. However, there seems to be no 
statistically significant differences in the regeneration between young and old zebrafish 
within the first days after amputation. This data proposes that the capability of zebrafish 
to initiate the process of regeneration is not impaired in 40-month-old fish but is 
significantly declined at around 8 dpa when the outgrowth of the fin is typically rapid. 
This phase is also characterized by the development of bone structures and pigmentation 
(Pfefferli and Jaźwińska, 2015).  
 
In the present study, the decline observed at 8 dpa was especially interesting as it seemed 
that in old fish there was a slight decrease in the growth length from day 6 to day 8. This 
may be due to technical challenges in measuring the fin length or it may relate to the 
reshaping of the white excrescence during the outgrowth of the fin. In order to evaluate 
this more detailed, further studies with better imaging tools should be performed. The 
images taken with smart phone camera via microscope to image the caudal fin were 
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surprisingly good in quality, but especially measuring the transparent excrescence was 
challenging from some of the images. 
 
In order to understand the mechanisms behind the decline in regenerative capability in 
old zebrafish, further analyses, such as gene expression analyses should be performed, 
especially from the timepoint when the decline was statistically significant. Also, studies 
continuing until full regeneration of caudal fin would be valuable in order to see if the 
decline still worsens over time.  
 
3.3.2 Drug study with larval zebrafish 
 
The effects of six different angiogenic or antiangiogenic compounds on the regeneration 
of larval zebrafish caudal fin were investigated in a 48-hour drug study. With angiogenic 
compounds tazarotene and roxadustat toxicity was observed with all doses. In roxadustat 
group, the used doses were 2.5, 15 and 50 µM. However, due to the lethal toxicity 
observed during the study, statistical analyses were possible only with the group with the 
dose of 2.5 µM. In this group, the decline in the regeneration of caudal fin was statistically 
significant (p = 0.0008). In the group that received 15 µM dose, toxicity was observed at 
least in the heart, yolk sac and intestine areas. The effect of roxadustat, inhibitor of HIF 
propyl hydroxylase, on the regeneration of larval zebrafish caudal fin has not been studied 
earlier. However, Jain et al. (2016) successfully used the dose of 2.5 µM for inducing 
hypoxia in zebrafish larvae. They treated larvae with roxadustat from 96 hpf until 102 
hpf, which is much shorter than in the present study, in which the larvae were treated for 
48 hours. Also, the initiation of the treatment was later in their study whereas in the 
present study roxadustat treatment was started at 48 hpf. Kim et al. (2020) used the doses 
of 15 and 50 µM in cell cultures for inducing hypoxia but treated cells only for 3 hours. 
Thus, it is possible that the doses used in the present study were too high and the length 
of the treatment was also too long. Instead of continuous exposure to roxadustat, shorter 
baths in drug water could be tested. 
 
With retinoid acid agonist tazarotene toxicity was observed with all the selected doses (1, 
3 and 9 µM) in a dose-response manner. The higher the dose, the more impairment in the 
caudal fin regeneration was seen. In all groups, this impairment was statistically 
significant (p < 0.0001). In addition, developmental deformities were visually observed 
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at least in the heart and yolk sac areas. The effects of tazarotene on the regeneration of 
larval zebrafish caudal fin has not been investigated earlier. However, the teratogenic 
effects of retinoids have been known for long and shown in several studies (Kistler et al., 
1990; Bechter et al., 1992; Collins and Mao, 1999). In adult zebrafish, treatment with 
retinoid acid have been shown to cause teratogenicity in caudal fin after amputation, but 
not in pectoral fins (Géraudie et al., 2002). In addition, no improvement on fin 
regeneration were observed at least by Géraudie et al. (2002). However, due to the in vitro 
and in vivo potential of tazarotene in wound healing shown by Al Haj Zen et al. (2016) 
this compound could still be tested with lower doses in adult fish.  
 
No effects with selected doses of 1, 10 ja 100 µM deferoxamine on zebrafish caudal fin 
regeneration were observed in the present study. Iron chelator deferoxamine has been 
used in several in vitro and in vivo wound healing studies, but not in studies concerning 
the regeneration of larval zebrafish caudal fin. However, angiogenic effects of 
deferoxamine have been studied in larval zebrafish (Pawar et al., 2020). Pawar et al. 
(2020) used deferoxamine as an angiogenic control with concentrations of 25, 50, 100 ja 
200 µM and reported a value of 55.8 µM as an effective concentration that is able to cause 
a change of 30 % in subintestinal vessels. Hamilton et al. (2014) for their part has reported 
a median lethal concentration of 1000 µM. Based on these findings, it is possible that in 
the present study the used concentrations were too low. One possibility is also that 
deferoxamine actually improved angiogenesis in zebrafish larvae, but not enough to 
affect caudal fin regeneration. The results in the present study may also be affected by 
the deterioration of deferoxamine in the 96-well plate during the 48-hour incubation at 
28.5°C. It is stated in the product information sheet of deferoxamine that solutions 
deteriorate during storage and fresh solutions should be prepared upon usage (Product 
information sheet, Sigma-Aldrich, 2021), but in practice it is difficult to evaluate how fast 
does this deterioration progress at the incubation temperature.  
 
Hypoxia-mimetic compound cobalt chloride has been widely used both in in vitro and in 
vivo research for investigating the effects of hypoxia at the molecular and cellular levels 
(Muñoz-Sánchez and Chánez-Cárdenas, 2019). In the caudal fin of adult zebrafish, cobalt 
chloride has been shown to increase blood vessel formation and accelerate regeneration 
(Eyries et al., 2008: Sagayaraj and Malathi, 2017). For hydroxylase inhibition, dose as 
high as 10 mM is needed with zebrafish larvae, but this dose also causes off-target toxicity 
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(Saeedi Saravi et al., 2009). A dose of 5 mM was successfully used with larvae in order 
induce retinal neovascularization with low mortality (Wu et al. 2015). In the present 
study, no improvement on caudal fin regeneration was seen with any of the used doses 
(1, 5 and 10 mM). However, some toxicity was observed with the highest dose of 10 mM 
as 6 larvae in the group were lost. In order to see any possible effects of cobalt chloride 
on angiogenesis, the blood vessel density in the regenerated caudal fins should be 
analyzed. Even if effects on angiogenesis could have been seen, the treatment for 48 hours 
may have been too short to improve caudal fin regeneration. 
 
NO donor sodium nitroprusside has been shown to accelerate the appearance of certain 
blood vessels in the trunk of zebrafish larvae (Pelster et al., 2005). The potential of many 
other NO donors in improving wound healing has been shown both in vitro (Bove et al., 
2007) and in vivo (Witte et al., 2002), but sodium nitroprusside has not been tested earlier 
for the regeneration of larval zebrafish caudal fin. Based on the present study no effects 
with this drug were seen on the caudal fin regeneration in larvae. These results could be 
due to low doses (0.1, 1 and 10 µM) used in the study. For instance, Leite et al. (2012) 
used a dose of 1 mM for treating larvae aged 7 dpf for 4 hours. Sodium nitroprusside is a 
short-acting NO donor (Carreiro et al., 2009), thus it is possible that the effect of the drug 
in the present study was too short. With higher dose and by changing the incubation 
medium containing the drug to new at least once or twice during the study, some effects 
on regeneration could have been seen. It is also important to note that low levels of NO 
(<100 nM) have been shown to promote angiogenesis and cell proliferation in vitro, 
whereas high doses (>500 nM) have been reported cause cytotoxicity and apoptosis 
(Burke at el., 2013). Thus, careful dose titration is likely needed also with larval zebrafish. 
 
The efficacy of antiangiogenic VEGFR inhibitor semaxanib on MDA-MB-231 breast 
cancer cells has been studied for instance in zebrafish xenografts (Nakayama and 
Makinoshima, 2020). In the present study the inhibitory effect of semaxanib on larval 
zebrafish caudal fin regeneration was statistically significant (p < 0.0001) with the highest 
dose of 10 µM, but not with the lower doses of 0.1 µM and 1 µM. These results indicate 
that more dose titration should be done in the future studies in order to find the lowest 
effective dose. In order to prove that the inhibitory effect of semaxanib was due to 
impaired angiogenesis and not to toxicity, further analyses should be also done. For 
instance, the blood vessels could be analyzed with fluorescence microscope as transgenic 
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Tg(fli:EGFP) zebrafish line was used in the study. In this transgenic line, the expression 
of GFP is driven by the endothelial marker fli1. The visualization of the vasculature in 
the regenerated caudal fin in zebrafish larvae would be valuable also with the other 




Impaired wound healing and the lack of effective treatments for chronic wounds are a 
significant, worldwide concern. Aging is considered as one of the biggest risk factors for 
chronic wounds. The lack of proper preclinical in vivo models for wound healing 
complicates drug development. Due to these facts, one of the aims of the present study 
was to investigate the mechanisms behind impaired wound healing during aging by 
setting up a wound healing model with fast-aging turquoise killifish strain GRZ. With its 
median lifespan of 14 weeks, GRZ provides an excellent and cost-effective tool for aging 
studies. However, several difficulties were faced when trying to set up this model, thus 
no wound healing experiments could be done with the strain. In order to eventually set-
up a turquoise killifish GRZ strain in laboratory, many detailed modifications concerning 
breeding and egg incubation are needed. 
 
Despite of the mentioned challenges, the impairment in wound healing due to aging was 
studied with turquoise killifish (strain MZCS222) and zebrafish. These fish 
species/strains are longer lived than turquoise killifish strain GRZ with their median 
lifespans of 33 weeks (MZCS222) and 3.5 years (zebrafish). Due to slow aging process, 
these species are not very convenient in the laboratory setting for aging studies, but they 
can still provide valuable data concerning aging-associated decline in the regeneration of 
caudal fin. Based on the present study, it was observed that aging impairs the regeneration 
of caudal fin in zebrafish, and previously Kosonen (2020) has shown this same decline in 
old turquoise killifish strain MZCS222. Thus, both of these fish species could be used as 
models for impaired wound healing. In killifish, the results from the present study suggest 
that the impaired regeneration of caudal fin could be linked to the decline in VEGF 
production and further on angiogenesis. Angiogenesis has a significant role in the wound 
healing process. VEGF as an inducer for angiogenesis has a substantial role in human 
wound healing and based on the results from the present study, also in turquoise killifish. 
However, further studies should be performed in order to understand the underlying 
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mechanisms behind the impaired regeneration in both turquoise killifish and zebrafish 
during the whole regeneration process. 
 
The effects of several angiogenic and antiangiogenic compounds on the regeneration of 
adult turquoise killifish and larval zebrafish caudal fin were also investigated in the 
present study. With VEGFR inhibitor semaxanib, which was selected as an 
antiangiogenic control drug, a decline in caudal fin regeneration both in old turquoise 
killifish and larval zebrafish was seen. This finding suggests that semaxanib impairs the 
regeneration of caudal fin by affecting angiogenesis and consequently also the later 
phases of regeneration. However, it would be of great importance to find also an 
angiogenic control drug for wound healing studies as the effects of roxadustat remained 
modest in the present study. In turquoise killifish, a slight improvement on the caudal fin 
growth rate with roxadustat was observed by Kosonen (2020), but no supporting results 
were found from the gene expression analyses or from histology in the present study. 
Also, in the studies with zebrafish larvae, no improvement on caudal fin regeneration was 
seen with angiogenic compounds roxadustat, tazarotene, sodium nitroprusside, 
deferoxamine and cobalt chloride. These results are probably related to several things, 
such as drug concentrations, toxicity, possible deterioration of the drugs and the used 
model. Therefore, more investigation with angiogenic compounds in both larval and adult 
zebrafish and also in adult turquoise killifish is needed in order to further validate the 
wound healing models. After further validation, modeling wound healing for instance in 
fast-aging turquoise killifish GRZ could be a valuable tool to study aging-related decline 
in wound healing and to screen new, potential drugs for wound healing in the preclinical 
phase of drug development. This kind of fish model could potentially accelerate drug 
development by reducing the number of expensive and time-consuming rodent studies. 
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4. Materials and methods 
 
4.1 Laboratory set-up of turquoise killifish strain GRZ 
 
4.1.1 Raising juvenile fish 
 
The diapausal eggs of turquoise killifish GRZ were received as a kind gift from Czech 
Academy of Science. The eggs had been stored in dry peat in plastic bags at room 
temperature several months. When the hatching of the eggs was started, one plastic bag 
containing peat and eggs was emptied into a 5 l glass tank and wettened with 2-3 liters of 
15-17°C system water (pH 7.3-7.6, temperature 27°C ± 2, conductivity 230 µS ± 30) to 
trigger the hatching. In later hatching experiments, the embryos developed in the 
incubator were directly moved from incubator to hatching tank. The tank was moved to 
a warm room with the temperature of 26°C near heater and positioned to a 20-30° angle 
for allowing the hatched fish to fill their swim bladder in the shallow end of the tank. 
Also, oxygen tablets (Oxylette, Hobby) were added in the water (1 tablet/l) to aid the 
hatched fish to fill their swim bladders.  Prior to hatching and additionally as soon as any 
signs of hatched fish were seen, the fish were fed with Artemia salina. The nauplii of 
Artemia salina is used for feeding juvenile fish. Artemia can survive in fresh water only 
for some hours, thus the feeding of the fish was done 2-3 times a day. The decapsulation 
protocol for Artemia is attached in appendix 1. 
 
Three days after hatching the killifish were moved to a bigger 40 l tank with aeriation. 
Water heater was added to the tank for keeping the water temperature at 28°C.  The faeces 
and uneaten Artemia were cleaned from the tank bottom 2-3 times a week and 
concurrently about 50% of the water was changed to fresh prewarmed system water. After 
10 days, chopped blood worms (Akvarie Teknik) in addition to Artemia were provided 
to killifish for 5 days in order to habituate them to eat more nutritious food. After 
habituation, the fish were placed individually to 40 l tanks attached to circulating system 
water. Individual housing was used at first in order to prevent the fish from cannibalizing 
smaller fish in the same tank. Finally, the fish were group housed (2-4 fish per tank) to 
60 l tanks 4-5 weeks post hatching and fed with bloodworms once or twice daily until 





For breeding turquoise killifish strain GRZ, group spawning was started when the fish 
had reached sexual maturation, approximately 5 weeks post hatching. The spawning was 
initially tried in a 10 l glass tank filled with system water. A mesh was placed on the 
bottom of the tank for preventing the fish from cannibalizing the eggs. One male and two 
females were placed in the tank to avoid possible violent harassment by the male. The 
tank was placed overnight near the heater in a warm room with the temperature of 26°C. 
After overnight mating, the fish were placed back to their original tanks attached to 
circulating system water. The spawned eggs were collected by pouring and flushing the 
mating tank water through a tea sieve. The collected eggs were gently washed with system 
water on a petri dish to get rid of unwanted organic material, such as feces. After this, the 
eggs were checked under microscope for evaluating the fertilization. The fertilized eggs 
were placed on a clean petri dish filled with E3 medium containing 0.624 µM of 
methylene blue (Sigma-Aldrich) for preventing any bacterial growth and transferred into 
the incubator with the temperature of 28°C.  
 
Due to poor success in spawning, the use of sand substrate as a trigger was tried. The sand 
(particle size 2-3 mm in diameter) was placed on a plastic box (figure 20) with dimensions 
of 8 cm (height) x 20 cm (length) x 10 cm (width), and the box was placed in the tanks 
of the fish. The box containing the sand was flushed with system water 2-4 times a week, 
and the eggs were collected by pouring the water from the sand box through a tea sieve, 
after which they were checked for fertilization.  
 
 
Figure 20. Plastic box used for spawning containing system water and sand substrate. 
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4.1.3 Incubation of eggs 
 
The development of the fertilized eggs was checked under stereomicroscope regularly 
every 2-4 days until the eggs reached ready-to-hatch state. E3 incubation medium 
containing 0.624 µM of methylene blue was changed to new 2-3 times per week. As the 
survival of the eggs in the incubator was challenging due to contaminations and some 
other unknown reasons, the petri dish was changed to a 24-well plate for individual 
incubation of eggs. Also, to avoid bacterial growth in the wells, gentamicin (Sigma-
Aldrich) was added to E3 medium containing methylene blue for obtaining final 
gentamicin concentration of 2 µM. The fertilized embryos reached ready-to-hatch state 
approximately in 15-18 days. As a sign of this, gold-pigmented irises were clearly visible. 
After reaching ready-to-hatch state, the embryos were kept in the incubator for 1-30 days 
before hatching was started. 
 
4.2 Wound healing studies with turquoise killifish strain MZCS222 
 
4.2.1 Preparation of cDNA 
 
RNA samples from turquoise killifish MZCS222 caudal fin had been collected in 2020 
from the drug study by Kosonen (2020). In addition, RNA samples were collected from 
the study in which the wound healing between young and middle-aged killifish were 
compared. The extracted RNA was stored at -80ºC for reverse transcription. The High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was used for the 
conversion of extracted RNA to single-stranded cDNA, and the reverse transcription was 
performed according to manufacturer’s protocol. Either 100 ng or 200 ng of RNA was 
converted to cDNA. The total reaction volume prepared was 20 µl with the sample and 
kit components. The reactions were performed using T100 Thermal Cycler (Bio-Rad). 
Finally, the cDNA samples were stored at -20 ºC until qRT-PCR measurements. 
 
4.2.2 qRT-PCR measurements 
 
The genes selected for closer investigation in the present study were chosen based on 
literature and with the help of CellMarker database (Zhang et al., 2019) in which the data 
concerning different biomarkers has been gathered comprehensively. The primary 
interest in the present study was in the genes involved in angiogenesis, but also to find 
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new housekeeping genes for turquoise killifish as control genes. Primer design for 
selected genes was performed with the help of NCBI primer design tool (Ye et al., 2012). 
The primers for angiogenesis-related genes vcam1, tie1, cd34, vegfa, melanoma cell 
adhesion molecule and lymphatic vessel endothelial hyaluronan receptor 1 were selected 
for the study. Housekeeping genes tbp, insulin receptor and hypoxanthine guanine 
phosphoribosyl transferase were tested for their potential as normalization genes. For 
each gene, the selected primers were evaluated for the specificity of the amplification 
signal (appendix 2).  
 
Before qRT-PCR measurements the prepared cDNA samples were diluted to 1:10 with 
nuclease-free sterile water (Accugene) for obtaining the final RNA concentration of 0,5 
or 1 ng/µl. For the amplification and detection in PCR reactions, SYBR Green PCR 
Master Mix (Applied Biosystems) was used. qRT-PCR measurements were performed 
using diluted cDNA samples, and four replicates for each sample were prepared. 8 µl of 
prepared master mix containing forward and reverse primers and 2 µl of diluted cDNA 
were pipetted into the wells of 96-well PCR plates to obtain 10 µl reaction volume per 
replicate. Sterile water was used as a negative control. The plates were sealed with 
adhesive seal, centrifuged in 2200g for 2 minutes, vortexed on a plate mixer and 
centrifuged again in 3500 rpm for 2 minutes. The run files with settings (appendix 3) were 
prepared using QuantStudio 12kFlex Real-Time PCR System software and the actual 
qRT-PCR measurements were performed by Plate Running Service at Turku Bioscience 
Center. The results were evaluated in relative quantification application by Thermo Fisher 
Cloud.  
 
4.2.3 Tissue processing for histology 
 
The regenerated pieces of caudal fins collected in March 2020 from turquoise killifish 
MZSC222 after drug study had been fixed and stored in 10 % neutral buffered formalin 
(FF-Chemicals) until September 2020. The fin pieces were further processed and 
embedded to paraffin on a frontal plane in histology service provider HistoCore, 
University of Turku, through an ascending series of ethanol (70 %, 96 % and absolute) 
and clearing in xylene. After processing, 4 µm sections from embedded samples were cut 
with a microtome in HistoCore. Prior to MG and PHH3 & CNA35 double staining, the 
paraffin was removed from the sections with xylene (Sigma-Aldrich) and the sections 
 50 
were rehydrated through a descending series (absolute, 96 % and 70 %) of ethanol (VWR 
Chemicals).  
 
4.2.4 Masson Goldner’s staining 
 
One section from each caudal fin sample embedded in paraffin was stained using MG 
staining kit for histology (Sigma-Aldrich) intended for visualizing connective tissue. 
Weigert’s iron hematoxylin kit (Sigma-Aldrich) was used for nuclear staining. The 
staining was otherwise done according to the protocols of the kits, except for the 
incubation times for light green and hematoxylin. Due to the low color intensity, the 
incubation times were prolonged from 5 minutes to 12 minutes (light green) and from 2 
minutes to 12 minutes (hematoxylin).  The stained sections were mounted with Depex 
(Merck). After overnight drying at room temperature, the sections were scanned with 
Pannoramic P1000 Digital Slide Scanner (3D Histech). The scan files in mrxs file format 
were converted with 3D Histech converter for enabling the images to be opened in QuPath 
(version 0.2.3) software, a free platform for analyzing histological whole image slides 
(Bankhead et al., 2017). In QuPath, the number of blood vessels in each section was 
manually calculated. Analysis was done blinded. 
 
4.2.5 Double staining of phospho-histone H3 and collagen-binding adhesion protein 35 
 
PHH3 & CNA35 double staining was performed for 4 µm paraffin embedded fin sections.  
Polyclonal rabbit Phospho-Histone H3 (Ser10) Antibody (Cell Signaling) and Donkey 
anti-Rabbit secondary antibody conjugated with Alexa Fluor 647 (Invitrogen) were used 
for detecting mitotic cells in the tissue. CNA35 (Macherey-Nagel) fused into fluorescent 
pET28a mCherry vector was used for staining collagen. Purification of the protein had 
been done in 2019 by the technical assistants in the laboratory, and the purified probes 
were stored at -80°C until use. The protein concentration of the purified CNA35 mCherry 
was 7.65 mg/ml and molecular weight 60 kDa. The used concentrations were 1:200 
(PHH3), 1:1000 (secondary antibody) and 1:100 (CNA35), and they were all diluted to 
10 % FBS (Gibco) in PBS. After deparaffinization, antigen retrieval was performed in 
Retriever 2100 (Aptum Bio) using Universal Buffer (10x, R Universal, Aptum Bio) 
diluted to 1x concentration with MilliQ water. Following antigen retrieval, the two 
sections on each slide were circled with PAP pen (Invitrogen). Unspecific binding was 
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blocked by incubating sections in 10 % FBS for 1 hour. The slides were incubated with 
the primary antibody overnight at 4ºC protected from light. The other section on the slide 
was left as an unstained control, thus it was left without antibody. After overnight 
incubation, the primary antibody was washed away with PBS. Following PBS wash, the 
slides were incubated with secondary antibody at room temperature for 1 hour protected 
from light. For background staining, DAPI (Thermo Scientific) was diluted with PBS to 
the concentration of 0.002 mg/ml. Sections were incubated at room temperature for 10 
minutes with DAPI protected from light. After washing with PBS, the slides were 
mounted with water based mounting media Mowiol 4-88 (Calbiochem) containing 2.5% 
DABCO (Sigma-Aldrich) as an antifading agent. The mounted slides were stored at 4°C 
protected from light. The mitotic cells and the collagen area in the sections were 
calculated and measured in Fiji image analysis software (Schindelin et al., 2012). 
Automatic thresholding was used for both analyses.  
 
4.3 Wound healing study with young and old zebrafish 
 
Wound healing studies with adult zebrafish were performed under the animal licenses 
ESAVI/16458/2019 and ESAVI/2402/2021 obtained from the Animal Experimental 
Board. 24 wild-type male zebrafish aged 4 months (12 fish) and 40 months (12 fish) were 
used for investigating wound healing between young and old zebrafish. At D0, the fish 
were individually anesthetized with tricaine methanosulfonate (Ethyl 3-aminobenzoate 
methanesulfonate, MS222, Sigma) diluted in system water to the concentration of 200 
mg/l. As the depth of the anesthesia was deep enough, the fish was transferred on a petri 
dish lid. The caudal fin of the fish was carefully spread on top of the lid and photographed 
with a smart phone camera attached to Zeiss stereomicroscope. After this, a piece of 
caudal fin was cut away distally with a scalpel from the cleft in the center of the fin (figure 
14 in Results) and the fin was photographed again. Finally, the fish was housed 
individually in a 1 l recovery tank containing 0.004 % of methylene blue in system water 
and placed in a warm room with the temperature of 26°C for the whole duration of the 
study. The tank water containing methylene blue was changed to fresh system water at 2 
dpa and every other day after that. The caudal fin of the fish was photographed at D0, D2, 
D4, D6 and D8. The fish were fed every other day just before anaesthesia for 
photographing the caudal fin. At D8, the regenerated piece of caudal fin was cut away 
with a scalpel under anaesthesia and stored at -80°C. The fish used for the study were not 
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euthanized after the experiment but left alive for future mating purposes. The length of 
the regenerated part of the fin was measured manually in Fiji (Schindelin et al., 2012) 
both from the ventral and the dorsal side of the fin. 
 
4.4 Drug study with larval zebrafish 
 
According to EU Directive 2010/63/EU the use of zebrafish embryos/larvae for scientific 
purposes until the age of 5 dpf are not defined as protected, thus they are not subject to 
regulations concerning animal experiments. Therefore, no license for these experiments 
was needed.  For each drug experiment, 3 male and 3 female fish from transgenic Casper 
zebrafish line Tg(fli:EGFP) were transferred to each 3 l mating tank filled with system 
water. The tanks were transferred overnight to a warm room with the temperature of 26°C 
and maintained at 12h light/12h dark cycle. Next morning the embryos were collected 
from mating tanks and checked under microscope for fertilization. The fertilized embryos 
were placed on ⌀10 cm petri dishes (approximately 50 eggs per dish) containing 25 ml of 
E3 incubation medium (0.33 mM CaCl2, 0.33 mM MgSO4, 5 mM NaCl and 0.17 mM 
KCl in MilliQ water). Finally, the petri dishes were transferred to incubator in the 
temperature of 28.5°C. The following day, at 1 dpf, the petri dishes were checked, and 
possible dead embryos were discarded. Embryos were also transferred to clean petri 
dishes containing fresh E3 medium. 20 µl of 20 mg/ml pronase E (Streptomyces griseus 
neutral proteinase, Actinase E; Serva) solution in E3 was also added for stimulating the 
hatching of the embryos. 
 
At 2 dpf, the hatched embryos called larvae from 2 dpf onwards, were anesthetized in 
0.16 g/l tricaine methanosulfonate (MS222, Sigma Aldrich) E3 solution containing 0.002 
% Tween 20 (Sigma-Aldrich). The anesthetized larvae were placed on a petri dish with a 
small amount of tricaine solution. Approximately 1/3 of the total fin length measured 
from cloaca to the tip of the caudal fin was cut away distally with a scalpel (figure 18A 
in Results) under AxioZOOM V.16 microscope. Following the wounding, the larvae were 
also imaged under the microscope using Nikon 1x objective and 25x magnification. 
Finally, the larvae were transferred to a U-bottom 96-well plate and tricaine solution was 
carefully flushed away with E3 medium.  
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The test compounds for wound healing study were diluted to different concentrations 
(table 3) in DMSO (Sigma-Aldrich) or MilliQ water depending on the instructions in 
product specification sheets.  Stock solutions from cobalt chloride, sodium nitroprusside, 
tazarotene and deferoxamine were prepared 2-5 days before the study and from 
semaxanib and roxadustat one year before the study. All the stocks were stored at -20ºC. 
Three concentrations for each compound were selected for this study based on literature 
(table 3). Prepared stocks were further diluted to E3 medium prior to the start of the 
treatment to obtain the chosen concentrations. Depending on the mating success, the 
larvae were randomly divided to groups of 12-20 larvae/concentration for the study. The 
treatment was started by replacing E3 medium in wells with 200 µl of test compound or 
control solution (E3 or 1 % DMSO in E3). The larvae were kept in the incubator at the 
temperature of 28.5°C for 48 hours and then anesthetized again by adding 10 µl of 4 g/l 
tricaine solution in each well of the 96-well plate. After this they were individually 
transferred on a petri dish and imaged under AxioZOOM V.16 microscope with the same 
settings as in the beginning of the study. Finally, the larvae within the same concentration 
of the compound in question were pooled and fixed overnight with 4 % paraformaldehyde 
(Thermo Fisher Scientific) in PBS containing 0.2 % of Tween 20 at 4°C. The length of 




Table 3. The used compounds and concentrations with possible references in larval 
zebrafish wound healing study. 
 





Sigma-Aldrich 1 M in 
MilliQ 
water 
1*, 5* and 10 
mM† 
* Wu et al., 
2015 
† Saeedi 
Saravi et al., 
2009 
Deferoxamine Sigma-Aldrich 10 mM in 
MilliQ 
water 
1, 10†, and 100*† 
µM 
* Pawar et al., 
2020 
 † Chen et al., 
2014 
Roxadustat Cayman Chemical 
Company 
25 mM in 
DMSO 
2.5*, 15† and 50† 
µM 
* Jain et al., 
2016 
† Kim et al., 
2020 
Semaxanib Santa Cruz 
Biotechnology Inc.  
10 mM in 
DMSO 
0.1, 1* and 10 
µM 




Sigma-Aldrich 10 mM in 
MilliQ 
water 
0.1, 1* and 10 
µM 
* Leite at al., 
2012 
Tazarotene Sigma-Aldrich 20 mM in 
DMSO 
1; 3* and 9 µM * Al Haj Zen 
et al., 2016 
 
4.5 Statistical methods 
 
All statistical analyses were performed in GraphPad Prism version 9.0.0 for Mac (La 
Jolla, California, USA, www.graphpad.com). For histological and gene expression 
analyses, one-way ANOVA followed by Dunnett’s post-hoc test for multiple 
comparisons was used for comparing the differences between the groups in the drug 
study. Two-way ANOVA followed by Šidák’s multiple comparisons test was used for 
comparing the differences in caudal fin regeneration between old and young zebrafish. In 
addition, two-way ANOVA followed by Šidák’s multiple comparisons test was used for 
the comparing the gene expression between young and middle-aged turquoise killifish. 
For investigating the statistical differences in the survival of two different turquoise 
killifish strains, a Log-rank test was performed. A p value of < 0.05 was considered 
significant in all analyses, and NS indicates a p value of > 0.05. One asterisk indicates a 
p value from < 0.05 to 0.01, two asterisks a p value from < 0.01 to 0.001, three asterisks 
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6. Abbreviations list 
 
Ang-1  angiopoietin 1 
CD34 cluster of differentiation-34 
CNA35 collagen-binding adhesion protein 35 
D study day 
dpa  day(s) post amputation 
dpf  day(s) post fertilization 
HIF-1α hypoxia-inducible factor 1α 
MG  Masson-Goldner’s 
MMP matrix metalloproteinase 
NO nitric oxide 
PHH3 phospho-histone H3   
RAR  retinoid acid receptor 
ROS  reactive oxygen species 
Tbp tata-box binding protein 
Tie1 receptor tyrosine kinase with immunoglobulin-like and EGF-like  
domains 1 
VCAM-1 vascular adhesion molecule 1 
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8.1 Appendix 1: Decapsulation of Artemia 
 
Approximately 20 g of Artemia cysts (Ocean Nutrition) were hydrated in 16 g/l salt 
(Royal Nature) water in a hatching cone attached to aeriation. After this, 94 ml of 
precooled salt water and 7,5 ml of 40 % NaOH (Fisher Scientific) were added in the 
hatching cone. Finally, 300 ml of 5 % household hypochlorite was added and the color 
reaction in the cone was carefully followed. During the decapsulation of Artemia, the 
color of the prepared solution in cone will change from brown to orange. Following color 
reaction, the cysts were collected on a collection sieve and flushed with running tap water. 
After this, the cysts in the sieve were placed in 0.1 g/100 ml sodium thiosulfate (Fluka) 
for 1 minute, rinsed with tap water and finally also with 16 g/l salt water. In order to 
dehydrate the cysts, 1000 ml of super-saturated brine (salt content 400 g/l) was added in 
the cone together with the cysts. Aeriation was connected and 18-hour incubation at room 
temperature was started. After incubation, the cysts in brine were aliquoted to 50 ml 
falcon tubes and stored at 4ºC for further use. During the raising of the juvenile fish 
approximately 30 ml of cysts in brine were added in hatching cone daily with 1 liter of 
16 g/l salt water and incubated for 18 hours at the temperature of 28°C before serving 
them to fish. 
 
8.2 Appendix 2: Evaluation of the primers 
 
The expression of angiogenesis-related genes vcam1, tie1, cd34 and vegf were analyzed 
in the present study. Also, primers for lymphatic vessel endothelial hyaluronan receptor 
1 (lyve1) and melanoma cell adhesion molecule (mcam) were tested, but these primers 
did not work. Housekeeping genes tata-box binding protein (tbp), insulin receptor (insr) 
and hypoxanthine guanine phosphoribosyl transferase (hprt) were tested for their 
potential as normalization genes. All of the tested primers for housekeeping genes 
worked, but as hypoxia may potentially downregulate the expression of insr (Arcidiacono 
et al., 2020), it was decided to select either tbp or hprt. As no differences between the 
expression were seen between them, tbp was randomly selected as the normalization gene 
for calculating relative quantification values. Tested primers and their sequences are 
listed in table 1. The selected primers for each gene were evaluated for the specificity of 
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the amplification signal. Primers were considered inadequate if multiple peaks as an 
indicator of off-target amplification were observed in melting curves. Examples for 
evaluating the suitability of tested primers are presented in figure 1.  
 
Table 1. Primers selected and tested for their functionality in the study with their 
sequences and references.  
 
Gene Forward/reverse Functionality 
(yes/no) 
Reference 















































Figure 1. Evaluation of the tested primers was done based on amplification and melting 
plots. A) Primers for mcam showed several peaks in melting plot, which is an indicator 
of nonspecific amplification. B) Hardly any amplification was seen with the primers for 
lyve1. C) Primers for tbp showed specificity in amplification signal. 
 
8.3 Appendix 3: qRT-PCR settings 
 
qRT-PCR settings used in the present study are listed in table 1. 
 
Table 1. qRT-PCR settings used in the study. Retrieved from Thermo Fisher Cloud 
application. 
 
Phase Temperature Time Ramp speed Cycles 
Hold:  
Step 1: UDG activation 
50ºC 2 min.  1.6 ºC/sec - 
Hold:  
Step 2: Dual-Lock DNA 
polymerase activation 
95ºC 2 min. 1.6 ºC/sec - 
PCR:  
Step1: Denaturation 
95ºC 15 sec. 1.6 ºC/sec 40 
PCR:  
Step 2: Annealing and 
extending 
60ºC 1 min. 1.6 ºC/sec 40 
Melt Curve:  
Step 1: Denaturation 
95ºC 15 sec. 1.6 ºC/sec - 
Melt Curve:  
Step 2: Annealing 
60ºC 1 min. 1.6 ºC/sec - 
Melt Curve:  
Step 3: Denaturation 
(dissociation) 
95ºC  15 sec. 0.05 ºC/sec. - 
 
